<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by /r/21dotco on Medium]]></title>
        <description><![CDATA[Stories by /r/21dotco on Medium]]></description>
        <link>https://medium.com/@emergingtechnology?source=rss-dc4be46c8af------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*tmrVq9Rk_7Eydlo-ZxbHbQ.jpeg</url>
            <title>Stories by /r/21dotco on Medium</title>
            <link>https://medium.com/@emergingtechnology?source=rss-dc4be46c8af------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 12:53:32 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@emergingtechnology/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Before We Can Add Years to Life, We Must Add Life to Years]]></title>
            <link>https://medium.com/@emergingtechnology/before-we-can-add-years-to-life-we-must-add-life-to-years-eb846f7657c8?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/eb846f7657c8</guid>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Wed, 17 Aug 2016 07:55:47 GMT</pubDate>
            <atom:updated>2016-08-17T07:55:47.295Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*c6dciGMXk7KuACsU.jpg" /></figure><p>The correlation between telomere length and age is very strong. Shorter telomeres directly correspond to shorter human life expectancy, but “cause and effect” are still debated. Finding ways to prevent telomere shortening could be an ideal way to address these issues and answer the question once and for all: Does prevention of telomere shortening extend our lifespans? Dr. Laura Briggs of <a href="http://www.sierrasci.com/">Sierra Sciences</a> presented on the subject of the organization’s research at the Aging ’08 conference in Los Angeles, California in a presentation titled “Before We Can Add Years to Life, We Must Add Life to Years.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/128/0*tp35VqBzhd9MCepL.png" /></figure><p>The following transcript of Laura Briggs’ presentation at the Methuselah Foundation conference entitled ”Understanding Aging: Biomedical and Bioengineering Approaches” has not been approved by the speaker. <a href="http://www.vimeo.com/1503383">Video</a> is also available.</p><p><strong>Before We Can Add Years to Life, We Must Add Life to Years</strong></p><p>First, I would like to thank Dr. Aubrey de Grey and his staff for inviting us to speak. It is truly an honor for myself, as well as <a href="http://www.sierrasci.com/">Sierra Sciences</a>, to share some of the work we’ve done. I have to thank Jerry Shay for providing most of the introduction, so I will be able to breeze through some of these slides and maybe spend more time on some of our data.</p><p>This is a picture of Woody Brown. He is ninety-five years old and still surfing in Hawaii. Wouldn’t we all like to age as well as he has? When we talk about life extension, of course it is not just about living longer but having increased healthspan. We have to consider then that almost anything we are going to do to extend the lifespan of our normal cells is potentially also going to expand the lifespan of our cancer cells. That is something that we are absolutely going to have to deal with. Based on that, I want to take a short tangent to talk about cancer just a little bit and how it relates to aging and telomeres.</p><p>Anything that decreases cell proliferation potentially then is a tumor suppressor pathway. Replicative senescence or telomere shortening is known to be like a cellular clog that stops cell proliferation once the telomeres get to a critically short length. As I said previously, we are still going to have to deal with the idea that turning on telomerase in an effort to lengthen telomeres is then going to bring us back to the cancer issue.</p><p>The cells we are interested in, these cells really aren’t cancer yet, right? They maybe are not pre-cancerous cells, but they are cells that lack growth control. Somewhere along the line they have acquired a mutation that has allowed them to bypass cell cycle regulators. If we think about a historical timeline of cancer, then eventually, as these cells continue to divide, their telomeres get shorter and shorter, and eventually they are going to become immortal, either through induction of telomerase activity or the ALT pathway.</p><p>When we are talking about extending lifespan and finding ways to turn on telomerase, we are not really interested in these cells — it’s a little bit too late. In these cells now, we are into curing cancer and fixing things that went wrong. It is actually these cells that we are most concerned with in our field of telomerase activation. We do not really have a good name for these cells, and we found this interesting. We asked people, <em>What do we really call these cells?</em> We have not really found a good answer, but they are critically important to anybody that is trying to extend lifespan.</p><p>Another big question that needs to be answered is, How prevalent are these cells? Is there a whole lot of them? We are going to have to develop means to not only identify these cells, but then deal with them as we are attempting to extend lifespan. What are some of the solutions then for life extension?</p><p>We heard a little bit last night about this portion of the SENS theory. One thing we could do is delete hTERT, as well as the ALT pathway. This would then stop the cancer cells. What would happen in addition, though, as a result of deleting the hTERT gene, is our telomeres in our stem cells are going to get shorter and shorter. We are going to have to deal with that issue. One way would be to infuse the body with stem cells on a regular basis that had these pathways knocked out. This is a very elegant way, and is just a portion of the SENS idea.</p><p>Aging is a hugely complicated process, and multiple facets are going to have to come together for us to actually cure aging. As parallel efforts, we would suggest cure aging — not necessarily our company, but the community — without inhibiting telomerase. Then, once we get to that point, we turn telomerase on. We would suggest too, telomerase induction in a transient environment. It would not be turned on all the time, but a small molecule — one we could take that would turn it on for a few months, extend the telomeres, and then take it away — would be a much safer method than having telomerase turned on all the time in the cell.</p><p>Telomerase might not be such a bad thing, because we do know there is quite a bit of evidence that telomerase will actually decrease the risk of cancer. We will hear more about this area as the conference goes on. One thing that we are pretty confident about is bad things happen when telomeres get short. Understanding the cause and effect relationships there is something that we still need to work on.</p><p>In cells, in cell culture anyway, preventing telomere shortening will extend the healthspan and lifespan of those cells. Unfortunately, we do not know if that is going to apply to humans. Can we extrapolate what we know about cell cultures to humans? That is a question that has not been answered yet. That is the fundamental question that Sierra Sciences is attempting to answer. We would love to get to this point and answer this question.</p><p>There are a number of diseases that could be helped by the prevention of telomere shortening. With that I will start with what I came here to talk about, which are some of the tools that we are using in the struggle to keep our telomeres long. Sierra Sciences has been in existence for about nine years. We have worked really hard trying to figure out all we can about telomerase. We have spent quite a few years doing telomere promoter analysis. We spent a couple years trying to find the transcription factors that actually bind to the telomerase promoter in areas we believe is involved with regulation. Through these efforts, on the side we were always taking anything we saw in the literature, any small molecules or processes, and asked ourselves if this was the answer to our question.</p><p>Unfortunately, we were not able to reproduce any of the work that is in any of the published documents. We could make a lot of HDAC inhibitors work in a transient transfection assay, for instance using the telomerase minimal promoter driving expression of a reporter. HDAC inhibitors work very well to induce activity of the telomerase promoter in that context. In terms of the indogenous promoter, we have not been able to do it.</p><p>That really set us back. If you think about a company that is working with normal cells, trying to turn something on that is turned off, and you set up the best controlled experiment you can imagine, what does a negative answer tell you? Not necessarily a whole lot.</p><p>We have a lot of collaborators, and they would say, “How do you know that that normal cell is even telomerase competent? Maybe telomerase has been turned off so long that you will never be able to turn it on. Even if you turn on the message, how do you know that the cell is then capable of processing it correctly and ending up with an actual active protein?” We are very diligent — we don’t take ‘no’ for an answer — and struggled with this for a long time. We now have been doing a lot of screening. We now have a 300,000 compound library and are searching for compounds that will turn on telomerase.</p><p>This is the result of one of our screens. It may not look like much, but what we are seeing here is RT-PCR for hTERT, and you see here along the x-axis a series of numbers representing compounds from our compound library. The blue bars are actually GAP DH, so they are basically our control for the system. We have a MRC-5, which is a human fetal lung fibroblast cell line that is ectopically expressing telomerase. You can see we get a whole bunch of message. The y-axis is showing raw Ct values — and if you are not familiar with RT-PCR, basically Ct is critical threshold. The more message you have in your sample, the more quickly you will pass a critical threshold. In this case, we are looking for lower numbers. The lower the number, the more message we have.</p><p>What really got us excited was this little blip right here. Actually, we have been teased so many times that we were only cautiously optimistic. We repeated it a bunch of times, of course, and saw this same thing happen over and over again. Here we have demonstrated a compound that is capable of inducing telomerase message.</p><p>We have not shown that we have active protein yet. In order to assay for active telomerase protein, we do a TRAP assay. This is based on the idea that we can use an artificial telomere. If telomerase is in the samples, then it will extend the telomeres. The telomerase then adds telomere repeat regions six bases at a time successively onto the end of the telomere.</p><p>If you run this product on an electrophoresis gel, then what you see is a latter that represents PCR fragments — telomerase created and then amplified by PCR — that are six base pair differences in length. Here, in this particular gel, we are seeing HeLa, which is a cancer cell line. We usually put 100% HeLa and 5% HeLa on our gels. 100% just means we had a hundred thousand HeLa cells. 5% means we had five HeLa cells and 95 normal cells that were lysed, so we use it as a quantitative effort. Here we see MRC5 cells that are negative for telomerase.</p><p>This is our 57,684th compound in our library. On the 57,684th compound we tested, we finally saw a little blip. We call this compound C0057684, but because that is a mouthful, I am going to say “57684.” When we exposed normal cells to our compound 57684, and this is an experiment done in triplicate, this is the first time we have ever seen something actually turn on telomerase activity in a normal cell. This was a huge breakthrough for our company. It validated what we had been doing all along, all of our screens.</p><p>What I want to do now is show you some of the work, and it’s fairly new, investigating this compound. We have done some dose curves. It is dose responsive. This is mRNA relative to HeLa. Everyone seems to know HeLa and telomerase, so we had pretty much done that. Across the x-axis you see increasing concentrations of 57684 and you can see a concentration-dependent increase in telomerase message. When we then run trap assays — and I have truncated the work here, I have started with just the 15 micromolar — we start to see a hint, and then increasing amounts.</p><p>We have looked at a time course to see how quickly does it turn on. Here we have added a compound to normal cells and then assayed for activity various hours later. You can start to see it at 24 hours, it peaks at 48, and by 96 hours we have pretty much lost the activity. We have also done some extinction work, where we look to see how long telomerase hangs around after we have removed the compound. Here you can see that 48 hours after we have removed the compound we are seeing a significant reduction in telomerase activity.</p><p>We have tested this in other cell lines. Maybe it was a fluke, right? These are two other fetal lung fiberblasts, MRC9 as well as IMR90. They both respond to the compound. We have tried foreskin fiberblasts. Again, they respond to the compound. We have looked at keratinocytes, and this is a phenomenon that we have seen in other cell lines. These are adult keratinocytes and neonatal keratinocytes, and the younger cells seem to respond more strongly to the compound than older cells. We have also looked at some confluent versus non-confluent cells and see a similar phenomenon. It seems to suggest that for this compound to work, the cells need to be actively dividing.</p><p>Because we were unable to repeat other labs’ work on other occasions, we felt really strongly that we would in no way say we had a compound that worked until we had independent verification. We were fortunate enough to have Jerry Shay and Woody Wright’s lab test it for us. They have been able to repeat the results in different cell lines. Judy Campisi has also repeated it for us, and Richard Allsopp at the University of Hawaii. We are thankful for their participation in this effort, and now we feel pretty confident that we can say compound 57684 does induce hTERT expression.</p><p>Another compound we have had the privilege to work with, and actually it is a neutraceutical, is a compound called TA-65. TA-65 is derived from the astragalus root. It is a compound that was identified by Geron Corporation and is now being commercially distributed by <a href="http://www.tasciences.com/ta65molecule.html">TA Sciences</a>.</p><p>This is TA-65 in keratinocytes. You can see, while not strong, telomerase activity in response to TA-65. We now have two compounds that we can use that seem to act a little bit differently too. TA-65 is not as concentration responsive as 57684 and seems to express telomerase at lower levels. We have asked ourselves about immortal cells, and old cell lines respond to 57684 with increased message. We are still figuring out exactly how to do TRAP on these cells. TA-65 does not seem to affect cancer cells. That probably is good news.</p><p>We have done TRAP assays on HeLa cells. You can see 50% and 70% relateive to the 57684. It is not only increasing message but it is increasing active telomerase compound. We have looked at a few other positive telomerase cell lines. In most cases we see increases in expression. Maybe the downside of 57684 is it is mildly cytotoxic. 48 hours after treatment with DMSO, we see confluent image. We see here that with 57684, we really have not had a lot of cell growth. We do not see dead cells — we just see reduced number of cells. This is concentration dependent.</p><p>We wondered if these cells were actually alive or not. We did some dead cell assays. In this particular image we see light microscopy. You can see here, we see all live cells. It looks like we are not killing the cells. One thing we also know is that when we take the compound away, the cells recover and start to grow again. TA-65 on the other hand is not toxic at all to the cell at these concentrations.</p><p>When we looked at some other toxicity indicators, in this case this is measuring ATP levels, these are fiberblast cell lines, and we see a reduction in ATP levels with an increase in concentration. I don’t know if this is representing any toxic effects on metabolism, because we have less cells at these higher concentrations as well. I do not think it is reflecting effects in metabolism — I think it is reflecting effects in cell number. Interestingly enough, when we look at cancer cells, we see a much stronger response.</p><p>Of course, as soon as we showed this data to Dr. Shay, he said it must be a DNA damage response. Indeed, it may well be. We do not really have a clear answer to this. We have work in progress with Dr. Shay’s lab on Gamma H2AX, although it is not very large scale and the results are inconclusive.</p><p>We had never seen in the literature any proof that DNA damaging agents actually turn on telomerase. There is what we would call circumstantial evidence, but nowhere did we find TRAP assays where we saw increases in telomerase activity. We stopped and asked ourselves whether a DNA damaging agent will actually turn on telomerase. We used an etoposide here, a widely recognized DNA damaging agent, and asked ourselves if it turns on telomerase. Here you can see hTERT message relative to HeLa. We compared 57684 to etoposide at two concentrations. 30 micromolar seems to be the concentration most widely used in the literature for studying etoposide as a DNA damaging agent.</p><p>You can see that we do see some increase in message with the etoposide. At 30 micromolar, it does not seem to be as responsive, though 57684 does increase much more than the etoposide. We have hypothesized that maybe the answer to this is that 30 micromolar etoposide is really toxic to the cells, and so most of these cells are dying. We need to further investigate those results.</p><p>We get really excited when we see a compound so we can hit it with everything we’ve got. We have done some DNA array analysis on these compounds, and maybe another unfortunate result for 57684 is that it is affecting a tremendous amount of genes, way too many for us to be thinking that this is the compound. 1700 of the genes have been upregulated twofold or more. We are still in the process of analyzing these and have about three different companies looking at this for us. It seems so far that the vast majority of these, the most significant genes affected are cell cycle control genes. There are some DNA damage response genes that are upregulated, but they are at much lower levels.</p><p>TA-65 is not showing these kinds of results. It seems to be very specific and is only increasing a handful of genes. We have done some extension of lifespan studies. It is probably premature a little bit, especially given the fact that the compound affects cell proliferation rates. We have done them anyway.</p><p>You can see here that continuously exposed normal cells at all concentrations that we have tested are not allowed to grow. Conversely, when we did a 96-hour treatment and then took it away, then followed these cells over time, we see a very modest increase in cell proliferation. Really not much to write home about at this point. We are continuing these studies and have a lot of different scenarios we are working on.</p><p>What is next for us? We are focusing on screening more than we are focusing on characterizing 57684. We are going to look at other cell types. We are interested in synergy — maybe TA-65 and 57684 mixture, or maybe HDAC inhibitors with 57684 to see if we can loosen up the chromatin a little bit. We have been working on some mechanisms of action and structural activity relationships, an attempt to develop more active and less toxic compounds, and of course replicative lifespans.</p><p>Here is RT-PCR of normal cells. Here we have analogs of 57684. We have about fifteen or sixteen in our compound library right now. You can see that some of the analogs result in a response, while others do not. We have an opportunity to look at structural activity relationships based on this, and when we do TRAP it follows the message really quickly. We continued to screen, and I want to say that these tools are freely available.</p><p>We are a small company and have an enormous amount of work to do, so we are really interested in collaborations. We are looking for researchers not only as collaborators, but also for people coming to work for us. If you have any interest in that, please talk to myself or some of the other Sierra Sciences people. I wanted to acknowledge Sierra Science’s staff. There is not any one person who does everything — it is just a huge collaborative effort. Thank you.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/550/0*Z7i-VnHBIqOVAFcx.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=eb846f7657c8" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Unfocused Pulsed Lasers Selectively Destroy Lipofuscin]]></title>
            <link>https://medium.com/@emergingtechnology/unfocused-pulsed-lasers-selectively-destroy-lipofuscin-f087bafd1f2d?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/f087bafd1f2d</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Wed, 17 Aug 2016 07:48:28 GMT</pubDate>
            <atom:updated>2016-08-17T07:50:18.650Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<p><strong>Unfocused Pulsed Lasers Selectively Destroy Lipofuscin</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*WgLnLM3MD05EUf56.jpg" /><figcaption>Gilad Lehmann and Nason Schooler at Understanding Aging: Biomedical and Bioengineering Approaches</figcaption></figure><p>December 1st, 2008</p><p>Lipofuscin accumulates in the lysosomes of aging post-mitotic cells and progenitor cells, interfering with autophagy. Thus it has been proposed that the removal of this indigestible aging pigment may be a highly effective rejuvenation therapy. It has been known for over forty years that pulsed unfocused lasers can selectively destroy pigmented structures without harming the surrounding tissue. Aging researcher <a href="http://www.nasonschooler.com/">Nason Schooler</a> offered his perspective on the potential benefits of the lipofuscin removal approach at the Understanding Aging scientific conference hosted by the Methuselah Foundation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/128/0*Dtz0F800KU39ZLCU.png" /></figure><p>The following transcript of Nason Schooler’s presentation at the Methuselah Foundation conference entitled ”Understanding Aging: Biomedical and Bioengineering Approaches” has been corrected and approved by the speaker. <a href="http://www.vimeo.com/1427419">Video</a> is also available.</p><p><strong>Unfocused Pulsed Lasers Selectively Destroy Lipofuscin</strong></p><p>We have a simpler view of this problem. It is overly simplistic, but it’s compelling. The basic idea comes from <a href="http://lib.bioinfo.pl/auth:Brunk,U">Ulf Brunk</a> in Sweden. Brunk and Terman have written a number of papers, and continue to do so, outlining this <a href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=18230825">mitochondrial-lysosomal axis theory of aging</a>.</p><p>It is very simple. The idea is lipofuscin is this aggregate of oxidized lipids and proteins that accumulates in autophagosomes or lysosomes. Lipofuscin itself we think is the problem. We think lipofuscin is sufficient to knock down autophagy as it accumulates. Eventually you get cells that are loaded with lipofuscin and the lysosomes cannot do their job of rejuvenating the cell. We think that many aspects of aging are the result. If that is true, this is where the whole idea of “removing the garbage” comes in. We think the garbage itself is the problem, and if we can get rid of it we can make some serious inroads into conquering aging.</p><p>My original hypothesis was that somehow, maybe we could use electromagnetic radiation to combat these pigments, whether their accumulation or whatnot. I really got onto this idea of specifically destroying this garbage, the lipofuscin (I’ll use lipofuscin as kind of a blanket term). The idea was, is there some way that we can use light, or infrared or radiation, any kind of electromagnetic radiation to get rid of these pigments? So, the first thing I do of course (this was like, last Fall), I start searching the literature like a madman and come across some fairly conventional things like photobleaching, photodynamic therapy, photobiomodulation… some of them were interesting and could be kind of useful, but not what I was really looking for.</p><p>Finally, I discovered this paper. It was written in 1983 and appeared in <em>Science</em>. It is by <a href="http://www.mgh.harvard.edu/mghdermatology/staff/anderson.htm">Rox Anderson</a>, who is like a dermatology guru at Harvard Medical School still, I believe. This paper outlined a theory on selective photothermolysis. The idea of selective photothermolysis is also quite simple.</p><p>If you have a target in the cell or in tissue that is pigmented and dense, light will selectively interact with that target. In this paper, they used melanin as their target of choice, since melanin is everywhere. They’re dermatologists, so they were interested in melanin in the skin. They showed very elegantly that with a short-pulsed laser at the appropriate frequency, they could selectively destroy melanin. Here is a picure (a blow-up) of a melanosome, and here is the cell — it’s largely intact still, but w e get exquisite destruction. This was a coherent globule of stuff, and it’s been blown inside out; and when I saw this, I was like, “Wow, we are so close.” What if you could do this for lipofuscin? Come to find out, as I dug deeper, it’s already being done.</p><p>We have heard about macular degeneration in particular a few different times. There is a treatment called selective retinal therapy that is at the bleeding edge of ophthalmology research. They use lasers that are pulsed or scanned, so you get a short exposure, to selectively destroy RPE cells that are clogged with lipofuscin and excess melanin. It works wonderfully. Basically the cells that are defective in their recycling capability are knocked out, the RPE is repopulated with cells that do not have this problem, and right there — that’s a microcosm of what we think is the aging process organism-wide. If you could do the same thing for the entire organism, there you go. Dermatology is another great example. Sorry, I don’t have a lot of time to get into it.</p><p>Here is our concept. Take a pulsed laser, hit a large portion of tissue with it, and only the cells that contain lots of lipofuscin will be affected; and if we choose our parameters right, only the lipofuscin granules themselves will be affected, and we could leave things like neurons and cardiac myocytes that we don’t want to get rid of — we could leave them intact. So that’s the general idea, and selective absorption means selective destruction. This has been shown in a number of papers — if you want to search the literature on SRT, and also the dermatology literature talking about removing age spots and tattoos and all kinds of things.</p><p>So if we want to use this as a therapy, what are the things that could go wrong? What are the obstacles? One of them, of course, is if lipofuscin is not the key problem — it is a downstream issue; and if that’s the case this will be very illuminating, because we’ll find out. Another problem is that maybe we’ll kill cells; and in the current treatments that is what happens. With the more basic, cruder parameters they’re using, you do end up killing cells — and they want to. So it’s kind of an anecdote in a lot of these papers, that you can destroy a melanosome, for example, without destroying the melanocyte; because they really want to destroy the whole cell in a lot of these cases. But the key issue is the actual pulse — the length and the shape of the pulse, and if you choose those things correctly you can get exquisite confinement of damage, which has been shown in some of these papers. And of course the shape of the pulse is also important — lots of parameters to play with.</p><p>The final issue is, maybe the lasers won’t penetrate deeply enough. It’s just a laser, right? How can you get it to go clear through your skin? Well actually there is this kind of “optical window” around the near-infrared range, say 800 nanometers, where you can get penetration of 2~3 centimeters, and still have effective levels of your energy to do what you want to do, and this has also been shown. So as an engineer, I would say hey, give me two or three centimeters — that’s an engineering problem, but we can probably reach just about everything there; and of course you can optimize that by choosing your frequency and things like that.</p><p>So here is a little bit about our research. If I have some time, I guess I can go over it a little bit. We are using the worm C. elegans as our model. We happen to have a green laser right now, which is probably not the best frequency for the worms. Hopefully it won’t matter — they absorb well. The main thing we’ve found so far, I mean we’ve just got the lab set up and going, but what we have found that if you take younger worms that don’t have much of this lipofuscin in them — they’re pigmented, but not much lipofuscin — you don’t see much destruction. In fact I can’t blow a worm up, even with the maximum dose that we can muster with a lens and with this laser.</p><p>However, you try the same thing on a twelve day-old worm that has accumulated lipofuscin, and the worm will blow up with one tenth of the energy. So therefore that tells us we’re actually reaching the lipofuscin. You don’t have to have melanin in the cell with it to help it out; and that’s a perfect proof of concept. We have to move on and find sub-lethal doses, use this in a lifespan experiment, maybe get some electron micrographs and see what is going on. There is a lot that has to be done.</p><p>In conclusion, we can get ultra-fine selectivity with ultra-short pulses — and that’s crucial to keeping cells alive, and not killing cells, that we don’t want to kill. This is a rich field with lots of things to look into. I have kind of a list of things here. There’s all kinds of different models we need to try this in. In a nutshell, this is way more than me, a lowly graduate student can possibly do in a sane amount of time. That is the main reason I am talking at this point — I want to get more interest in this, and get some more people grinding away at this.</p><p>So I would just like to leave you with a couple key points here. Initial results in our lab have shown that lasers can selectively affect the lipofuscin, so we are on the right track. It has been proven to penetrate several centimeters in soft tissue, at least. This is useful as a treatment in us, in mammals, in mice, things like that — very encouraging. Also it’s proven to selectively destroy pigments, leaving the rest of the cells and tissues intact. I say “proven” because if you look at the literature, especially in ophthalmology, the dermatology literature, and it is definitely there. To me, I think this has very exciting potential to postpone aging.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/550/0*x5ixgAQ4yb5lq61-.jpg" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f087bafd1f2d" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Natural Cancer Resistance in Mice and in Humans]]></title>
            <link>https://medium.com/@emergingtechnology/natural-cancer-resistance-in-mice-and-in-humans-2e909a6eff38?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/2e909a6eff38</guid>
            <category><![CDATA[life-extension]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Wed, 06 Jan 2016 05:02:50 GMT</pubDate>
            <atom:updated>2016-01-06T05:02:50.343Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*fmNKqcKyTs-1TCuQ.jpg" /></figure><p>November 28th, 2008</p><p>Zheng Cui is a biochemist currently serving as an Associate Professor of Pathology (Tumor Biology) at Wake Forest University. Last year his research into granulocyte therapy made headlines by achieving a complete cure for all types of cancer tested in mice.</p><p>As an oncologist and a cancer researcher he has proposed that certain individuals (estimated at 10% to 15% of the human population) naturally produce a special kind of white blood cell that contains an inherent resistance to cancer. These white blood cells could potentially be extracted from donors and given to cancer victims, thus endowing them with cancer resistance.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/550/0*rD_LO1iFOY5ERCbq.jpg" /></figure><p>The following transcript of Zheng Cui’s presentation at the Methuselah Foundation conference entitled “Understanding Aging: Biomedical and Bioengineering Approaches” has not been approved by the speaker. <a href="http://www.vimeo.com/1650186">Video</a> is also available.</p><p><strong>Natural Cancer Resistance in Mice and in Humans</strong></p><p>First of all, I would like to thank Aubrey for inviting me again. I spoke at the <a href="http://www.methuselahfoundation.org/files/sens3/">SENS 3 conference</a> last year. I think this project will attract a lot of public attention. In recent days I have had to deal with a lot of media interviews. Tomorrow morning you may read something in the newspaper, and some sites I believe have already posted their report on this talk. The main purpose for today’s talk is to announce the opening of this clinical trial.</p><p>We already have a <a href="http://www1.wfubmc.edu/tumorbio/srmouse/index.htm">website</a>, live today, as we talk. Perhaps you can go to the website and look at some details if you do not have the chance to get everything in the next twenty minutes. After last year’s conference in Cambridge, I was invited by the Chinese government to give a talk on Christmas, but the very next day I realized it was a very close call for me.</p><p>If you don’t read Chinese, you might not realize this is a public execution of violent criminals, so I was<em> that close</em> to getting myself into a lot of trouble. It gives you a similar sentiment that this is a very controversial project in terms of a basic science approach. We believe it is based on observations — some people call us phenomenologists. We proudly accept that name.</p><p>The main concept for this project is very simple. This idea, that we may have natural resistance to cancer present in our body at all times, is not a new idea. It has been proposed for over a hundred years. In other words, the reason that we are sitting here cancer-free is not because we’re lucky, it is because we may have an innate system in our body to protect us — in other words, to get rid of cancer cells. As we get older, this protection may get weaker. That balance between the generation of cancer cells on a continuous basis can overtake the ability of your body to get rid of them.</p><p>Where do we find evidence for this? When we look at the literature there is almost no direct evidence, but when we look a little bit harder we realize there are some really courageous experiments done in the 1950’s. If you read some of the older reports, you see that Dr. Chester Southam was injecting human subjects with live cancer cells. It was a very clear message intended to persuade the general public that there is a cancer resistance naturally present in our body, especially in healthy individuals. However, in cancer patients, this ability was lost. Because of all the legal and ethical problems of this entire line of study, it was shut down and almost disappeared. However, the scientific message was profound. A lot of people followed this idea, but there is no way that you can do a similar experiment.</p><p>In 1999, we did not design anything specifically to look for cancer resistance. It was merely a laboratory accident that led us to this interesting phenomenon. At the time we were trying to collect antibodies, so it was routine to introduce very aggressive cancer cells, which will kill the host in three to four weeks. No single mouse ever survived.</p><p>However, this mouse came along. We thought we forgot to inject this mouse. After several attempts, with increasing doses, he still remained healthy. That really surprised us. We thought this must be a very dramatic event because if no other mice survived, and he survived, there must be something there… but it is only one mouse.</p><p>It is very fortunate that this kind of survivability against cancer cells can be passed on to the next generation. That was ten years ago, and we still have a very large colony in our facility. It is 25 generations and several thousand mice later that it passed on with a dominant inherited trait. We also noticed that someone here was presenting on high throughput sequencing — this might be a great project for them. It is genetic, it’s inheritable, but we do not know what caused it. Perhaps these newer technologies can help us to answer this question in a very definitive way.</p><p>This is a picture of the original mouse a few weeks before he passed on of natural causes after a long and productive life. It makes me very jealous, but their life is measured in numbers — ours is not. We also realized before long that the reason for cancer resistance is because their immune cells are doing something to the cancer cells.</p><p>If you look at the wild type mice, cancer cells grow like crazy. However, if you look at the resistant mice, you put these cancer cells in them and in a few hours the cancer cells are in a lot of trouble. First you see these cells being surrounded, and second they are ruptured. This seems to be a typical immunological reaction. If you look at the EM, you can see that the cell interaction between the immune cells of the resistant host and the cancer cells is very tight. The immune cell latches onto the cancer cells and there is a surface erosion of these cells.</p><p>Physical contact is very important. If you block this physical contact, you can actually prevent this killing event. That suggests to us that cell-to-cell contact is very important. The cell has to get there and interact at the cell surface.</p><p>This is a picture of cell surface erosion. It also surprised us, there are two effector cells. If you are a cell biologist or a pathologist, you will immediately notice, this is macrophage, this is neutrophil. What are they doing there? It is a very interesting question. It is not supposed to be the cells that kill the cancer cells. Cancer immunologists are all about T cells and B cells, but what are these cells doing there?</p><p>This is a quick review of the two systems that we have and our mice have. We have an innate immune system that is rapid and ferocious. It is involved in cells such as natural killer cells, macrophages and neutrophils, and they can act within hours. The other is a more dedicated system. It is very low level, compared to the innate immune system, but very specific. Usually they require weeks, if not months.</p><p>Here is a quick review of our immune system. Granulocytes and neutrophils are a major component of this. 50 to 70% of our cells belong to this class of neutrophil, and there are other classes of granulocytes. The lymphocytes make up about 10% of white blood cells. 10 to 15% of the other cells are something we call monocytes. When they get into tissues they are called macrophages.</p><p>We realized that in these mice the macrophage and neutrophil keep popping up. The other thing is you can see that we challenged them four times, hoping to get an idea of what type of cells are involved in this cancer killing mechanism. We knew that this was an innate immune response. It is very rapid — within a few hours it can complete its task.</p><p>I still call myself a phenomenologist, because I have to be visually convinced of this kind of event. This is an experiment injecting cancer cells into these mice, and then, using time lapse microscopy, seeing what happened to them. In this case, the large cells are cancer cells. By the end of this video, all the cancer cells are captured by the immune cells. They form very large cell aggregates, where we know there is something happening. This is how the rosettes form, because you can even see how the turbidity in the test tube changes. The next event occurred after the immune cells captured the cancer cells. You see the cells rupture, almost like a balloon.</p><p>After I saw this, I was convinced that we were dealing with something I never saw before. This is my favorite video, which I call the “magic bullet.” This immune cells finds the cancer cell, and it pops. After you see this video, you have to believe that something is happening.</p><p>There are many requests from cancer patients and their families to move into human trials. Who cares if a mouse gets cancer? This is perhaps a transition we can make to human cancer. We have devised this cell killing assay, simply to mix immune cells collected from individuals and mix them with cancer cells. After a certain time of incubation, we count how many cancer cells were alive compared with controls.</p><p>Wild type mice have almost no cancer killing activity. Resistant mice have some activity even in human cancer cells. The resistance can cross species to kill human cancer cells. We can update this graph now that we have a lot more points, but the basic message is still the same. It looks like a normal distribution. Some people are high, some people are low, and most are in between. For people who are a little bit older, the average is lower. If you look at cancer patients, the trend is even lower.</p><p>This was an open label study. People challenged us to do a double blinded study. We said okay, so here is the double blinded. In a healthy subject, the ratio of cells are different there, but the point is very clear. The older you are, most people cannot maintain this number. In cancer patients the number is a lot lower. Even lower are dogs. Humans have an overall mortality rate of 25% due to cancer. For mice, it is about 80%. For dogs it is about 50%, so right in between human and mice populations.</p><p>The next questions was where this activity is. Is it in the agranulocytes or granulocytes? We realized that most activity is in the granulocytes. That was a big surprise to us. If you look at the granulocyte count in individuals, it can range from 50% to 75% of white cells. If you calculate that and compound them together, most of the cancer killing activity is in the granulocyte fraction. Is that broad spectrum or is it specific to one type of cancer? We realized that in cervical cancer, breast cancer, prostate cancer and sarcoma, all are killed to a relatively high degree similar to each other.</p><p>Here is another serendipitous discovery. We always run into the assay problem when winter comes. When Thanksgiving and Christmas comes around, I would say to the graduate students who do these assays, “You must be distracted by all the holidays. Keep working on the system until it starts to work.” They would go back to the lab, changing everything along the way, and after several months things would start to work again. However, we realized after several years that this always happened at the same time. We realized that it may be more than just making mistakes.</p><p>Beginning in 2005, we stopped changing things. We said, if we don’t change anything and it still goes through this pattern, it might be something else. We realized after messing around with all these different components, waters and assay solutions, it retained this pattern. It became very clear to us that this was a seasonality. Our immune function has a winter low and a summer high. It was quite a surprise to us, but it was very clear.</p><p>What’s wrong with winter? Our ancestors in the pre-technology era had to conserve energy during the winter, because they have no food availability like we have right now. The only way that our ancestors could survive winter was to reduce their metabolic rate. They would sleep a lot more, eat a lot less, and do a lot fewer things than they would otherwise during the summer.</p><p>If someone wanted to do this experiment, it would not be that difficult. If the seasons have such a profound impact on our anti-cancer immunity, what about areas that do not experience seasonal changes, like equatorial regions? This is World Health Organization data, and it shows that all the countries with a low incidence rate for cancer is near the equatorial region where there is no seasonal change. We were surprised to find this kind of correlation. Whether it is directly related, we don’t know. We hope that someday we can figure it out.</p><p>In humans, you can see that it is similar to the mouse. When there is this killing activity, the cancer cells are surrounded by neutrophils and macrophages. A student made another video to show whether human cancer cells can actually be killed by these isolated, highly purified granulocytes. You can see apoptosis and rupturing. The point is that whatever happened in mice whose cancer cells were killed, it happens in humans as well. The mechanism is very similar.</p><p>Whether this activity is stable within the summer months, here each color represents an individual. This low point, we later found out, was after a day of extreme emotional stress. It took three days to recover. The other anecdotal evidence we discovered relates to another low point for this individual. This is another one of my graduate students. I sent him to an international meeting to make an oral presentation for the first time in his life. He got really worked up for a few weeks.</p><p>On his way back, there is a point that we missed, because there were just not enough granulocytes to do the assay. The white cell count was wiped out, and he was in a lot of trouble.</p><p>You can see that we select a donor according to their activity and then use an apheresis machine to collect their granulocytes. The FDA approved this within thirty days. It was a very fast approval. This is published data. There is a similar strategy using manipulated white cells from cancer resistant mice, which can cure a large tumor. We published this in ’06. It got a lot of media attention.</p><p>Our institute was challenged with the assertion that this was not real cancer. They said you can induce prostate cancer by knocking out the p10 tumor suppressor gene. “If you can cure this, we will believe you.” We treated these mice with one injection of white cells from the resistant mice, and they all lived longer.</p><p>If you are a cell biologist and you look at these pictures of the prostate, you will recognize that this is scar tissue. This is very effective. What is the link between spontaneous regression and infection? There is a long history of suspicion that these two may be linked. <a href="http://en.wikipedia.org/wiki/William_Coley">William Coley</a> is the first one to be credited with this.</p><p>Based on our knowledge, we have granulocytes, monocytes and lymphocytes. The only connection is this: with bacterial infection, the increase is in granulocytes, by ten or twenty times — sometimes even as much as one hundred times. People have started to talk to me about possible collaborations. This is senator Tom Harkin, this is my lab, and the biggest credit should go to the mouse.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2e909a6eff38" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Trying to Muse Rationally About the Singularity Scenario]]></title>
            <link>https://medium.com/@emergingtechnology/trying-to-muse-rationally-about-the-singularity-scenario-9c9db2eb9ece?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/9c9db2eb9ece</guid>
            <category><![CDATA[douglas-hofstadter]]></category>
            <category><![CDATA[artificial-intelligence]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 12:23:47 GMT</pubDate>
            <atom:updated>2016-01-01T12:23:47.318Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*ibigZ19Q9i9bbpto.jpg" /></figure><p>November 9th, 2008</p><p><a href="http://en.wikipedia.org/wiki/Douglas_Hofstadter">Douglas Hofstadter</a> is College Professor of Cognitive Science and Computer Science, and Adjunct Professor of History and Philosophy of Science, Philosophy, Comparative Literature, and Psychology at Indiana University, where he directs the Center for Research on Concepts and Cognition.</p><p>His books include the Pulitzer Prize winning <a href="http://www.amazon.com/gp/product/0465026567/"><em>Gödel Escher, Bach: An Eternal Golden Braid</em></a>, <a href="http://www.amazon.com/gp/product/0465045669/"><em>Metamagical Themas</em></a>, <a href="http://www.amazon.com/gp/product/0465030912/"><em>The Mind’s I</em></a> (with Daniel Dennett), <a href="http://www.amazon.com/gp/product/0465024750/"><em>Fluid Concepts and Creative Analogies</em></a>, <a href="http://www.amazon.com/gp/product/0465086454/"><em>Le Ton Beau de Marot</em></a>, and a verse translation of Pushkin’s <a href="http://www.amazon.com/gp/product/0465020941/"><em>Eugene Onegin</em></a>. At the Singularity Summit at Stanford he stated his belief that the Singularity scenario, “even if it seems wild, raises a gigantic, swirling cloud of profound and vital questions about humanity and the powerful technologies it is producing. Given this mysterious and rapidly approaching cloud, there can be no doubt that the time has come for the scientific and technological community to seriously try to figure out what is on humanity’s collective horizon.”</p><p>The following transcript of Douglas Hofstadter’s Singularity Summit at Stanford presentation has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fplayer.vimeo.com%2Fvideo%2F33633966&amp;url=https%3A%2F%2Fvimeo.com%2F33633966&amp;image=http%3A%2F%2Fi.vimeocdn.com%2Fvideo%2F228434332_295x166.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=vimeo" width="432" height="240" frameborder="0" scrolling="no"><a href="https://medium.com/media/d60386faef98a6db3fbd922c7bbe7309/href">https://medium.com/media/d60386faef98a6db3fbd922c7bbe7309/href</a></iframe><p><strong>Trying to Muse Rationally about the Singularity Scenario</strong></p><p>As has been mentioned, this symposium is to a certain extent the successor to an e vent that was organized by me in the year 2000. It took place actually on April 1st of 2000. Everyone has given it the wrong name — it was not called the “Spiritual Machines Symposium,” but the “Spiritual <em>Robots</em> Symposium,” because I wanted to splice together the names of two books. One was <a href="http://metaverse.jeriaska.com/people/Ray-Kurzweil/">Ray</a>‘s <a href="http://www.amazon.com/Age-Spiritual-Machines-Computers-Intelligence/dp/0140282025/ref=pd_sim_b_shvl_img_2/103-7950109-3258258"><em>The Age of Spiritual Machines</em></a> and the other was Hans Moravec’s book called <em>Robot</em>. I took one word from each of them and made that symposium.</p><p>Now, why did I do that? It was in the early part of 1999 that two books were <a href="http://www.nytimes.com/books/99/01/03/reviews/990103.03mcginnt.html">reviewed</a> in the New York Times Book Review together by a philosopher named Colin McGinn. They were Ray’s The Age of Spiritual Machines and Hans Moravec’s <em>Robot</em>. I read this review with some degree of skepticism and perplexity, because I had never thought about the issues that were being raised by McGinn — but ultimately by the two books. I immediately went out and bought the two books and read them. I found them very disorienting and worrisome, kind of scary.</p><p>Now, why would I find these things scary? Well, that’s confusing, even for me — In 1993, long before all these things came to my attention, I had written an article for a newspaper called “Who will be We in 2093.” I added a hundred years and asked, “Is it possible that the human species as it evolves transforms so radically that it becomes very different from what it is like today, and perhaps it merge with or become subsumed in computers or robots of some fashion?” With my question — “Who will be We?” — I thought about whether it could be possible that ultimately our progeny could be things like robots that had inherited our culture but had carried it much further.</p><p>Now, I published this article in response to an event that I had taken part in in Holland that year. It was an event that had to do with computer intelligence. <a href="http://en.wikipedia.org/wiki/Joseph_Weizenbaum">Joe Weizenbaum</a>, famous for his book <a href="http://en.wikipedia.org/wiki/Computer_Power_and_Human_Reason"><em>Computer Power and Human Reason</em></a>, which came out in the 1970’s and was kind of a diatribe against the use of artificial intelligence in anything that would encroach upon human values, was one of the speakers at this event. <a href="http://en.wikipedia.org/wiki/Dan_Dennett">Dan Dennett</a>, my philosopher colleague, was there and we were speaking in some sense in favor of artificial intelligence.</p><p>Weizenbaum got up and delivered a shoe-thumping diatribe against AI, against its possibility, and for humanity, but “humanity” in its most ordinary sense — just who we are today. The entire audience rose to its feet at the end and gave him a huge standing ovation. He was extremely opposed to anything like computer intelligence, and I was really kind of shocked. It struck me as so parochial and such a narrow vision of what humanity could be.</p><p>When I originally published my article, I called it “Who will be ‘We’ in 2093?” I then had another opportunity to publish it, and I don’t remember where, but I changed the number. I changed it to 2493. I moved it away by 400 years — 500 years in the future. I think I was a little bit scared by my own predictions, or by my own imagery. Perhaps it was because, as a father of children, I was starting to think, “My goodness, I wonder if my children, or at least my grandchildren might be completely rendered superfluous by these kind of changes that I am talking about.” I didn’t like that idea, so I pushed it into the future. I’m not sure if it was these emotional pressures or the intellectual ideas, but I pushed it off.</p><p>Then in 1999, Ray’s book and Hans’s book came out, and I was struck by a combination of many things — I would say fear, confusion… uncertainty, I would say, most of all. I organized a panel at Indiana University consisting of people from many different disciplines to talk about this. I have to say that I was very shocked by the panel because it was as if I had never even asked them to read these books. Most of the panel members did not talk about any of the issues that I had raised, and I felt very dissatisfied. A few months later when I came out to Stanford on a sabbatical for a year, the people at symbolic systems particularly pushed me to try to do it again, so I did organize another panel. I got a very distinguished set of people, and I will talk about that a little bit later. My goal was, in some sense, to think rationally about the scenarios that had been suggested by these books.</p><p>The title of my talk today is”Trying to Muse Rationally About the Singularity Scenario.” Ray complained to me a little bit, very gently but reasonably I think, in an email a few days ago, saying that it suggested that I was the only one thinking rationally and that everyone else was thinking irrationally. That was an unintended interpretation of my title. I can see easily how that can be heard that way, but I did not mean it that way. I have no claim to be able to think more rationally than anyone else on this panel. In fact, I am very impressed by the rationality of Ray and of many other people, but I think that rationality exists in each of us in a slightly different form. I think that ultimately, in order to think about the likelihood of the kind of predictions that we are encountering, we need to have many people discussing it, which is what we have today. No one has a monopoly on rationality. In any case, I apologize for that kind of implication.</p><p>I have found very few people who are skeptical. There are some people who are skeptical in the sense that they don’t <em>like it</em>, but very few people who are skeptical in an articulate fashion. Let me tell you about my panel in 2000 very briefly. I invited both Ray and Hans to participate, and I was very pleased that they came. I invited <a href="http://www.kk.org/">Kevin Kelly</a>, author of <a href="http://www.kk.org/outofcontrol/"><em>Out of Control</em></a> and one of the editors at <a href="http://www.wired.com/">Wired</a>. I invited Ralph Merkle (a well-known nanotechnology person), <a href="http://www.wired.com/wired/archive/8.04/joy.html">Bill Joy</a> from Sun Microsystems, <a href="http://en.wikipedia.org/wiki/Frank_Drake">Frank Drake</a> (head of the SETI Institute), <a href="http://en.wikipedia.org/wiki/John_Henry_Holland">John Holland</a> (the inventor of genetic algorithms), and <a href="http://en.wikipedia.org/wiki/John_Koza">John Koza</a> (the inventor of genetic programming.) I was the moderator, so there were nine of us. I thought it was a very promising lineup, but unfortunately it did not quite work the way I had hoped.</p><p>Bill Joy commandeered at least half of the time by talking about the “low IQ” end of humanity scenario — that we are smothered by self-reproducing techno-dust. It was a valid issue, understand. It was by no means an invalid issue to bring up, but it was not what I had intended. A lot of the time was spent on issues that was not my intention. The “high IQ” end of humanity scenario, that is what I intended to talk about. You may not agree is the end of humanity; you may say that humanity is transformed. During that time there were only two people who voiced any skepticism at all about the “high IQ” end of the scenario. Those were, to my surprise, both of the people involved with genetic programming and genetic algorithms, John Holland and John Koza. They were very skeptical of the use of genetic algorithms or genetic programming to evolve high levels of intelligence.</p><p>I am not going to go into their skepticisms. That is not the main purpose of my talk. My talk is really more of a plea to have an articulate discussion about these things. In Ray’s new book, which I highly recommend, he has done a great deal of impressive research of all sorts. I read with great interest the sections about nanotechnology — which I knew very little about — and the things about nanotubes, which I knew something about — not as devices for computing, just some of the chemistry, because they are fascinating objects. I did not know much about them as potential substrates for computation. That was very interesting to read about. Of course, as you have seen, Ray is a past master at displaying exponential curves as straight lines by taking logorithms. The book is just filled with those kinds of things, and it is very interesting to contemplate. It has also got some very interesting responses to critics. Of course, close to my heart is the response to <a href="http://en.wikipedia.org/wiki/John_Searle">John Searle</a>, which I think he does a very good job at.</p><p>Nonetheless, I think there is some handwaving in the book. I think Ray would admit, he does not know what is going to happen in ten, twenty, thirty, forty years. He has a belief in the law of accelerating returns. He calls it a law and he wants it to be analogous to mathematical law and laws of thermodynamics. The difference is that in physics you use statistical mechanics and you derive the laws of thermodynamics. The laws of thermodynamics are rigorously derivable from statistics, whereas Ray’s “law” is not so much of a law as it is a tendency or a trend. He has certainly marshaled a great deal of evidence to suggest that it will continue. I am not saying it is wrong, you understand. I am just saying it does not have the same status as a scientific law.</p><p>It is a tendency, an extrapolation, but it is not a rigorous scientific law in any sense. It is a very interesting set of observations, with one paradigm supplanting another. Just as one winds down, the other one starts up — very interesting and provocative observations. Ray does not talk too much about the details of how the entire world will be simulated. He did not actually talk about uploading ourselves into cyberspace, but effectively that is one of the themes of the book. The idea is that after awhile we will all exist as software entities inside computing hardware — basically, that is our destiny. If that is the case, he did not talk about how we are going to also model or simulate the entire world. It is one thing to simulate a certain degree of complexity, and it is another thing to simulate many, many orders of magnitude more. I understand the argument of adding a linear number to the exponent and getting larger and larger exponents. Again, there is some handwaving going on at that level.</p><p>There are also blurs about what does it mean for humans to survive in cyberspace. What is a human being at that point? What demarcates one individual from another? Ray talks very about the merging and un-merging of human beings inside cyberspace, but it is not clear what a human being would be in such an environment. There are some claims in the book that I would cast some doubt on. For example, that computers today can compose pieces like Bach. I have spent a great deal of time looking into computer composition, and the most impressive I have seen is <a href="http://en.wikipedia.org/wiki/David_Cope">Dave Cope</a>‘s Emmy. Suffice it to say that I am not convinced that Emmy writes anything like Bach. I won’t go into that, but I think it is an exaggerated claim.</p><p>Ray suggests that computers understand natural language, at least if you take his cartoon seriously. “Understanding natural language” is on the floor; it’s not on the wall. He suggests that soon, thanks to things like <a href="http://en.wikipedia.org/wiki/Douglas_Lenat">Doug Lenat</a>‘s Cyc project, computers may have common sense. That seems to me to be pie in the sky, but that’s a personal interpretation.</p><p>Ray suggests that maybe our brains have only 10⁸ bytes worth of information in their structure because of the genome. Well, maybe, but what if it is really more like 10⁸ button pushes on a jukebox, where when you push the button on the jukebox you get a record out, and the record contains an unbelievable amount of information? You have to recall that inside neurons there are many thousands of proteins, but IBM’s supercomputer Blue Gene, the most powerful in existence, is supposed to simulate the folding of one protein. If a protein is that complicated, and if it turns out that intelligence does depend upon that — and I am not saying that it does, mind you — then we have a much longer way to go. Now, I know we can always say “add a few more years” to get those extra exponents, but it is not clear that we can always rely on the law of accelerating returns. It may be. I’m not here to cast doubt on that. It’s just not clear.</p><p>I think that I would like to show some of my reactions. When I opened the symposium six years ago, I used two cartoons. They were meant to show that I was basically a supporter of many of the ideas that Ray and Hans were proposing. I was not a gung-ho believer, but I felt that some of these standard objections were baseless. I want to show some of those cartoons and then a few others that I made specifically for this event.</p><p>Here we have two stones talking to each other some billions of years ago. One of them is saying, “Sentient life? Don’t make me laugh! Self-reproduction is impossible! Nothing can pack a description of itself inside itself! Infinite regress! Anyway, mere matter like us rocks can’t feel anything! No soul, no elan vital, no consciousness… Life!? The idea is self-contradictory — don’t you worry!” Then, on the right side we have a thunderstorm, lightning strikes the pond, and some form of self-organization takes place, and molecules appear. “Ribo ribo” you can interpret as “ribosome” or “ribonucleaic acid,” which is RNA, or deoxyribonucleic acid, which is DNA. However you want to interpret it.</p><p>This is basically intended to show that perhaps the most miraculous transition of all has already taken place — that is, from inanimate matter to life. That took place! That is a true miracle, but that took place. A lot of people don’t think about that when they think about these kinds of things.</p><p>Ray talks eloquently in his book about the jump from one-cell life to multi-cell life — that’s another wonderful transition, but let’s talk about this one. Two fish: “Sentient life on land? Don’t make me laugh! You couldn’t even breath! The idea is self-contradictory — don’t you worry!” Then we have our amphibian — “Ribbit, ribbit.” We do have transitions of the substrate of life. Some people might think that it is impossible for life to change substrate. That seems an absurdity. We have seen it change substrate to some extent.</p><p>Here is John Searle. “Sentient life in Silicon? Don’t make me laugh! Wrong stuff! Wrong causal powers! Chinese room! Just syntax, no semantics! Blah, blah, blah… Life in silicon? The idea is self-contradictory — don’t you worry!” And of course we have our computer saying, “Robot, robot.”</p><p>Now, our next one is about Ray’s ideas about the laws of accelerating returns. Here is where I have a little bit of skepticism. I’m going to poke a little bit of fun at Ray, but you have to understand it is with great respect. It’s a little fun, but it’s not meant to be ridiculous. “Hit a wall? Don’t make me laugh! Quantum computing, DNA computing, artificial evolution, nanotechnology! Pico! Femto! 10²⁰! 10³⁰! 10⁴⁰! 10⁵⁰! 10¹⁰⁰⁰⁰⁰⁰⁰⁰! Recursion! Faster! Smaller! Cheaper! Smarter! Double exponential today, triple tomorrow! Nothing can stop exponential growth! Limitations?! The idea is self-contradictory — don’t you worry!”</p><p>There is a lot of that kind of idea. I have exaggerated it; I’ve caricatured it — but a lot of those ideas exist in the book. I think one has to put some degree of skepticism into the thing. Of course, here is something that Ray mentioned — the idea of standard exponential explosion in rabbits. Here, we have something that could put a wall into the exponential explosion of rabbits.</p><p>Ray did not talk about this too much, but he talked about it a little bit. He talked about the end of disease, but he also talked about the end of mortality. Again, this is one of his themes — that we will become immortal. The subtitle of his second most recent book is “Live Long Enough to Live Forever.” There is a whole current of thought in what Ray is talking about of survival of some essence of who we are, forever.</p><p>“Live forever? Don’t make me laugh!” These are two people in wheelchairs who are not so much looking forward to the idea. “We are programmed to die! Everything eventually wears out! Planned obsolescence! The only thing certain is death and taxes! Immortality? The idea is self-contradictory — don’t you worry.” “Ray bet. Ray bet.” Ray is betting on immortality. He seriously is. He details this in his books. I don’t know if he would bet lots of money, but he’s betting his life on it instead.</p><p>Finally, once we are all up in cyber-heaven, how long can we stay there? “It will crash? Don’t make me laugh! We figured it all out! We have mathematically proven it cannot crash! Software verification! The idea is self-contradictory! Don’t you worry — nothing can go wrong, go wrong, go wrong…” “Reboot, reboot.”</p><p>Enough of my cartoons. They raise the issues. They are not necessarily expressing my own opinions. They are trying to raise the issues, to provoke, and to get people to think about this. Now, I am certainly a believer that life can exist in many substrates. I read a very interesting science fiction book called <a href="http://en.wikipedia.org/wiki/Dragon%27s_Egg"><em>Dragon’s Egg</em></a> by Robert L. Forward, a physicist who postulated the idea, based on an idea of Frank Drake’s, that life could come to exist in the crust of a neutron star. It is a very interesting speculation — whether it is reasonable or not, nobody knows.</p><p>I don’t see any reason in principle that such kinds of extreme forms of life could not come to exist. Nor am I an opponent of life in silicon, or life in carbon nanotubes. All of these things seem potentially plausible. I am not somebody who casts cold water on these ideas. I do, to some extent, not believe in the timeframes that Ray and Hans have put forth, despite their very interesting exponential curves, or linear lines in log space. They are interesting.</p><p>I think what I am really concerned about, after having read Ray’s most recent book, and been very impressed with many of the arguments in it, I ask the question: How realistic is this? I have asked a number of friends, highly informed intellectual people of different disciplines, and I have heard reactions over the following range: “The ideas are nutty — not worth the time of day.” “The ideas are very, very scary.” “I don’t know. I just don’t know.” “They are reasonable, or they are probable.” …But none of these people have read the book.</p><p>This is very interesting to me. What I find strange about this is that I get the feeling the scientific world is not taking any of this seriously. In other words, I do not see serious discussions of this among physicists when they get together. I see them all sort of basically say “poo poo.” I see most scientists have a sort of skeptical attitude. I’ve read the books, and I am still skeptical, but I am less skeptical. Why am I skeptical? Well, partly just because I am a little bit conservative. Maybe there is an emotional component in it. I am also skeptical because I think the ideas in the books unfortunately are somewhat marred by a blur with too much science fiction.</p><p>I will just mention this very briefly — I don’t want to get into it in any detail — but in Hans’s book there is a huge amount of stuff about time travel. There are five to ten pages about computers that will be based upon time travel, and the idea that when computers get sufficiently complex — and by “computer” he means something that is <em>way</em> ahead of what we have now; he calls them “Minds” with a capital “M.” — inside these “Minds,” all of the universe’s history will be recreated uncountably many times, including our own lives. These kinds of scenarios, which are so fantastic, are blended in seamlessly with the rest of the book. To me that renders the whole book somewhat contaminated. How secure can I be of the sanity of this person?</p><p>In Ray’s case, there are some similar things. It is hard to take it seriously, but you may disagree with me, the idea that he is going to be immortal. It is hard to take seriously the passages in his prior book, the idea of utility foglets–little molecules that will self-assemble into anything, from the Taj Mahal to a mountain range in a split second. It is a science fiction scenario at the most extreme level, but it is right there in the middle of the book. Ray talks about engineering down below the level of quarks, and he also talks about civilizations that would have commandeered the entire galaxy to do their information processing or their communications. To me these things also seem wild beyond any degree of speculation that I am willing to accept.</p><p>Again, I feel like my level of ability to believe in it is seriously damaged by these kinds of admixtures. Then there are some nitpicky things. Today Ray used the word genome very accurately — but in the book, every time he refers to the genome he refers to it as “the genetic code.” That is a very elementary mistake. That is like confusing an electron with a nucleus. The genetic code is a very specific four by four by four table that maps codons onto amino acids. Ray talks about the genetic code of an individual over and over again in the book. That undermines his credibility to me.</p><p>He talks about the “knee” of an exponential curve. Well, I’m sure he knows there is no such thing. An exponential curve is a very smooth curve — there is no special place in an exponential curve. All you need to do is take the logarithm and you see it is a straight line. There is no such thing as the “knee” of an exponential curve. These kinds of things to some extent reduce my level of belief, but they do not, by any means, make me stop believing that some of these ideas are possible.</p><p>I guess what I think is the following. When I read Ray’s book, I see a large number of things that I think are partially true. “Partially true” means — they’re blurry. I cannot put my finger on where they are wrong — there’s a lot of handwaving. When you multiply the partial truth of a bunch of things together, you get down to a very small number. Maybe a probability of one in a thousand of what Ray is talking about is actually taking place. Now, again, I’m just handwaving. When I listen to Ray, I feel like I am listening to one side of a divorce, and I am terribly convinced that this person is right and that the other side could not possibly be right.</p><p>I would like to hear serious scientists taking these ideas seriously and giving a serious skeptical response — not that I necessarily want it to be the other side. I want the debate to be very seriously taken. I think this is all to Ray’s credit. He has raised some terribly important issues. These issues suggest that we are about to be transformed in unbelievably radical ways. The subtitle of Damien Broderick’s book <em>The Spike</em> is “Accelerating into an unimaginable future,” and I think that is what is being suggested. I think we really have to take these ideas seriously, so that is my plea.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9c9db2eb9ece" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Being Good Enough]]></title>
            <link>https://medium.com/@emergingtechnology/being-good-enough-b9563248e5d0?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/b9563248e5d0</guid>
            <category><![CDATA[artificial-intelligence]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 12:14:09 GMT</pubDate>
            <atom:updated>2016-01-01T12:14:09.731Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*lRkLo9PsJzzAQ3YE.jpg" /></figure><p>November 2nd, 2008</p><p>Environmentalist <a href="http://www.billmckibben.com/">Bill McKibben</a>, a visiting scholar in environmental studies at Middlebury College, is the author of <em>The End of Nature</em>, the first book for a general audience about global warming. Published in 1989, it is now available in 20 languages.</p><p>His most recent book, <em>Enough</em>, critiques human genetic engineering, nanotechnology and other rapidly advancing technologies. It was his belief, posited at the <a href="http://sss.stanford.edu/">Singularity Summit at Stanford</a> that we need to decide that we live, most of us in the West, long enough. “In societies where most of us need storage lockers more than we need nanotech miracle boxes, we need to declare that we have enough stuff. Enough intelligence. Enough capability. Enough.”</p><p>The following transcript of Bill McKibben’s Singularity Summit at Stanford presentation has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fplayer.vimeo.com%2Fvideo%2F44144897&amp;url=https%3A%2F%2Fvimeo.com%2F44144897&amp;image=http%3A%2F%2Fi.vimeocdn.com%2Fvideo%2F306576529_295x166.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=vimeo" width="432" height="240" frameborder="0" scrolling="no"><a href="https://medium.com/media/6b1dcf574408e5e348d1c858efb13232/href">https://medium.com/media/6b1dcf574408e5e348d1c858efb13232/href</a></iframe><p><strong>Being Good Enough</strong></p><p>It’s a real pleasure to be joining you all today, albeit from afar. I wish I was there with you in person. I was actually born at Stanford hospital while my father was working at SRI in the early 1960’s, and it would be a great pleasure to meet those of you whose books and articles I have read with real interest and appreciation. I have met <a href="http://metaverse.jeriaska.com/people/Ray-Kurzweil">Ray Kurzweil</a>, and I want to thank him in particular for the spirit of non-dogmatic openness with which he approaches this topic, exemplified in this case by his eagerness to have me express my doubts about the question at hand. I’m afraid those doubts will dominate my talk.</p><p>I’m appearing to you more or less from the future thanks to Dave Kennedy and the handy crew here at <a href="http://www.teleportec.com/">Teleportec</a>. You will find me somewhat the voice of the past, or perhaps a different idea of the future. My doubts are not technical. I’m more than willing to grant, at least for the sake of argument, that something like what Ray and others have been calling the Singularity, or an intelligence explosion, or whatever term you use, may in fact be in the offering — a moment when some other intelligence outstrips that which we now call human, and when, as a result, everything changes. Human life would be, in Ray’s words, “irreversibly transformed, and with it the concepts that we rely on to give meaning to our lives — from our business models, to the cycle of human life, including death itself.”</p><p>Now, to desire such a future is relatively easy for us. The default assumption in our lives as modern Americans is that more is better: more stuff, more power, more intelligence, more years, more dimensions. When I say “default assumption,” that is just what I mean. In fact, we have come to call this assumption, and the set of traits that underlie it–curiosity, greed, technical prowess, competitiveness — we have come to call them “human nature.” This hyper-individualism is most fully developed in our own culture, and in recent times has produced a political ideology that bridles at any attempt to restrain it in the name of community.</p><p>I was thinking as I was preparing this talk about I wrote a number of years ago, called <a href="http://www.amazon.com/Age-Missing-Information-Plume/dp/0452269806">The Age of Missing Information</a>. It was an odd experiment that I recorded in this book. I went and found the largest cable television system in the world, which at the time was in Fairfax, Virginia, and had a hundred channels. I got people there to tape for me everything that came across those hundred channels for 24 hours. So I had 2400 hours worth of videotape — a kind of day-in-the-life of the information age, pre-internet. I took it back with me to the woods where I live, and I went to Sears and bought a recliner, and I settled in and watched, trying to figure out what the world would look like to you if this was your main porthole on it, as for many it is.</p><p>The book is filled with a lot of different ideas and insights, but the central one, and I think the message that flows out of that cable, and every other instrument of our consumer society, is that you, sitting there on the couch, are the most important thing in the world. You are the heaviest object in the known universe — everything should orbit around <em>you</em>. That’s a powerful idea. It’s worth remembering, however, that there have been and continue to be different conceptions of who we are and who we can be. A certain strain of powerful thinking that we sometimes call “spiritual” traces back at least as far as the Buddha, for instance, and argues instead that as we manage to make ourselves smaller we become more fully who we are.</p><p>Most human beings, in most times and places, have almost certainly defined themselves in connection to the community, the divine, the natural world — some amalgam of those three. It is not only spiritual traditions that lead us in that direction. To me, the most remarkable emergent science of the last century was neither atomic physics nor computerized mathematics. It was the insights of ecology, with its developing notion of balance and of niche.</p><p>Now, adjudicating a dispute between these two positions — this hyper-individualism and community — is, of course, difficult. Too much depends upon the assumptions and even the mood in which you begin. Let me register, by way of example, a couple of small examples — reasons to think that more is not always better. Advocates of various forms of transhumanism or other improvements will routinely point to human memory as one of our most obvious defects. Indeed, Eliezer said a few things about it a minute ago.</p><p>Marvin Minsky, for one, explaining why he did not “much like how people are now,” pointed out that we can only learn about two bits per second. Even a century’s worth of learning at that pace would leave us with only three billion bits of data, or less than what we can store today on a regular five inch compact disc. By now, doubtless, we can store that much on a disc the size of a housefly’s thorax. Perhaps, as Ray has written, we will soon have knowledge-loading downports in the electronic version of our synapses, so there will be no need to read a book, the computer will just squirt the contents into your head.</p><p>It’s easy, in a Midas-like mood, to yearn for perfect recall. But be careful in this, as in many things, for what you wish for. Isn’t one of the most remarkable features of the human memory precisely its ability to forget? Take the even more prosaic example of human physical performance. It will in all likelihood prove possible to make us faster and stronger than we are at the moment (genetically, pharmacologically) by melding us with machinery. We will then by some measure be better than we are now… but to what end, exactly?</p><p>I’m an athlete, albeit a slow one. I run marathons and race on cross country skis. A couple of years ago I qualified for the Boston Marathon, and there was no danger that I would win it, of course. Of the 20,000 people who started that race, at best ten of us had any real hope of triumph. And yet, it somehow was not meaningless. Indeed, half the people who crossed the line with me, an hour behind the victor, were in tears… and only partly because they were in pain. More importantly, it had been a very dramatic example of that most human of activities — finding out about yourself. What your limits were, how you dealt with them, what it felt like to be you.</p><p>To imagine the scene a few generations hence, when our same runners had been improved in utero so that their hemoglobin could carry four times the oxygen, or machined in some way so as to give them super speed, is to imagine the poverty of more. Yes, people will get to the finish line faster, but if getting there fast is the point, you had might as well take a motorcycle, or cross a person with a motorcycle, for that matter. The real point of the enterprise, self-discovery, would be fatally undermined. You would be discovering not yourself but your equipment.</p><p>For a rough analog, those of you in the Bay Area can conjure up this summer’s spectacle of Barry Bonds breaking baseball’s historic records. If it fills you with pleasure to watch his joyless pursuit, then the Singularity should be great fun for you. If not, it might be worth thinking more deeply. If the meaning of something as ephemeral as “sport” can be fatally damaged by improvement, then what of love, of art, of fate, of the central and profound human experiences? What of life itself?</p><p>One thing that came clear to me as I wrote this book <em>Enough</em>, and as I read and talked with many enthusiasts of the coming technological climax, was the degree to which this word was driven by a loathing of death. At some level this surprised me. Many scientists have long prided themselves on a willed immunity to the superstition known as religion that so many weaker souls embraced in the cold shadow of our own eventual demise.</p><p>Clearly scientists, some anyway, turn out to be as mortal as anyone, at least in their fear of mortality. Here is Michael West, the CEO of <a href="http://www.advancedcell.com/">Advanced Cell Technology</a>, which produced the first cloned embryos and grew them to the six cell stage. “All I think about all day long every day is human mortality and our own aging,” he said. Indeed, he talks about admiring a t-shirt he had seen with a picture of Einstein and the words “If he was so goddam smart, why is he dead?”</p><p><a href="http://www.damienbroderick.com/">Damien Broderick</a>, writing in his book <a href="http://books.google.com/books?hl=en&amp;id=E06oFLTW2lUC&amp;dq"><em>The Spike</em></a>: “We’re stuck at the moment with death’s pain, loss, and grief, but in the longest term of the history of intelligent life in the universe it will surely be the case that the routine and inevitable death of conscious beings was a temporary error, quickly corrected.”</p><p>Or Max More: “Involuntary aging and death is a rotten design feature for our species. It really is vital that we understand the causes of aging and how to intervene to stop it.” And hence the crusade, not to extend the average human life toward the edge of our genetic possibility, which is about 115 years, but to surge past the <a href="http://en.wikipedia.org/wiki/Hayflick_limit">Hayflick limit</a> and achieve some form of immortality.</p><p>Far be it for me to dismiss this deepest of human dreams. I would like simply to raise a few doubts, less about the practicalities, though “president for life” would certainly take on a new meaning, than about the most basic questions of meaning. For all our terms as mortals, we have been mortal — a creature that knows it will die. Consciousness is in many ways is the software for coming to terms with that knowledge, and without it consciousness would have little to rub up against.</p><p>Absent mortality, no time. All moments would be equal. The deep, sad, lovely, immensely human wisdom of <a href="http://en.wikipedia.org/wiki/Ecclesiastes">Ecclesiastes</a> would vanish. If for everything there is an endless season, then there is also no right season, and none of the profound daily joyful heroism of bringing up a child in the full knowledge that she will supplant you. There might be some being called a child in this endless future with whom you had some tangential biological or financial connection, but you would never pass on your life. Your child would be just one more figure in a sea of figures, owing you little, owing nothing in return.</p><p>The immortalists imagine that if one bite of the apple gave us consciousness, another bite or two, or really cramming the whole thing in our mouth at once, might take away the pain that came with consciousness. However, it is at least as likely that the next bite will erase human meaning instead. Meaning in pain and meaning in transience are inextricably intertwined. Immortality would not be <em>more</em>, it would be utterly different.</p><p>Here is Michael West again, answering a reporter’s question about whether immortality would not lead to overpopulation. “Perhaps it would,” he said, “but why put the burden on people now living, people enjoying the process of breathing, people loving and being loved? The answer is clearly to limit new entrance to the human race, not to promote the death of those enjoying the gift of life today.”</p><p>Now, now, me, today. Forget about the future, this is an attempt to stop time. You may be able, with some combination of these new technologies to live forever, but I have doubts about enjoying the gift of life eternally. The joy of it, the meaning of it, will melt away like ice cream on an August afternoon. I would suggest that living be enough for us, not living forever.</p><p>Let us turn for a moment to the interesting and perhaps slightly less philosophically daunting question of those very real problems that the world faces and how we might solve them. Let me raise, as an example, the question of climate change. I choose it for two reasons. One, it is the first civilization-scale challenge humans have yet faced. Two, it is the issue I have spent most of my life working on.</p><p>In 1989 I wrote the first book for a general audience about climate change, <a href="http://www.amazon.com/End-Nature-Tenth-Anniversary/dp/0385416040"><em>The End of Nature</em></a>. I have stayed with the question since. As all of you know, it represents a fantastically difficult problem: how to restrain the use of fossil fuels by 70% or more worldwide as soon as possible, even in the face of developing nations finally starting to develop, principally by burning coal.</p><p>Some of the answer to this yawning gap is technological. New fuel sources, new technologies for carbon sequestration — these are the problems that conceivably some form of superintelligence might help us solve, so it is worth pointing out that even with our puny single compact disc brains we have managed to construct most of the technology we need, ranging from the bicycle to the solar panel.</p><p>The other half of the equation, though, is not technological but behavioral. Let me give you an interesting statistic. The average Western European uses half as much energy as the average American. Half is a big number — not enough to solve global warming, but enough to get you a long ways there. Many of you have visited Western Europe, so you know they possess no secret technology. You know also that they are not living a deprived life.</p><p>Indeed, if we wanted to visit elegance and sophistication, we are more likely to board a plane for Paris than for Phoenix. The technology they possess is the technology of community. They have agreed to forgo a certain amount of consumption, for instance, and instead use the money to build cities attractive enough to exert a gravitational pull instead of spinning people off centrifugally into ever more distant suburbs. They have agreed to put high taxes on energy, to spend that money on building superb mass transit, and they are willing to put up with the mild inconvenience of using it.</p><p>This kind of technology depends on the very resources of the human mind and heart typically scorned by the techno-libertarian enthusiasts — indeed, almost all of the manifestations of a more-is-better culture. It helps show, in a sense, how tawdry that atmosphere can become, how it sells short the possibilities of the human.</p><p>Yes, as Max More stated in his address proposing amendments to the human constitution, we have limited senses, imperfect memories, and poor impulse control. Yes, as Gregory Paul and Earl Cox pointed out in their book <a href="http://www.amazon.com/Beyond-Humanity-Cyberevolution-Future-Minds/dp/1886801215"><em>Beyond Humanity</em></a><em>,</em> even the erect bipedal posture of which we are so proud makes us so unstable that falling on flat ground can have devastating consequences. Yes, as Nick Bostrom has predicted, it may be possible to engineer us so that we will have orgasms and aesthetic contemplative pleasures whose blissfulness vastly exceeds what any human has yet experienced… although, speak for yourself.</p><p>In fact, we already possess a singular and lovely ability, one unique to our species and one likely to be drowned in the oncoming Singularity which merges us with the machine and reengineers us for greater efficiency. That unique gift is the ability to restrain ourselves — to decide not do something we are capable of doing, to set limits on our desires, to say “<em>enough</em>.” This is, as I said at the start, an attribute that our spiritual traditions center on and that neither Copernicus nor Darwin has knocked askew. This deep tradition reminds us that meaning counts more than ability, achievement, or its simulation. Turning the other cheek is rather more impressive than building some titanium-girded hydrolic powered jaw that will let us chew gravel.</p><p>In recent time we have begun to see again, and in very secular terms, how right that sense of the world may in fact be. Scholars across a wide variety of disciplines have begun to ask in the last couple of decades a large question that academics have traditionally shied away from. Namely, “Are we happy?” The answer seems to be: “Not so much.” In this country, according to polls of annually surveyed Americans since the end of World War II, the number of our countrymen who will say they are very satisfied with their lives peaks in the mid 1950s and has declined slowly but steadily ever since. Barely a quarter of us will now make such a claim.</p><p>This is odd, since in that same span of time our prosperity has almost trebled. We have acquired huge new powers. Jet travel has become routine, for instance. Our houses have more than doubled in size, even as the number of people living in them has shrunk. We have, for a vanishingly small cost, access to prodigious amounts of information. Any semi-musical sound emitting by anyone on any continent can be downloaded instantly to that more or less permanently installed hard drive known as the iPod.</p><p>We are more enabled, empowered, more astride the world than anyone, anywhere at any time. Why isn’t it working so well? The Singulatarian answer to this dilemma is to say “yet more.” “Crank up the molecular assembler.” Once we can have everything we want the instant we want it, we will finally reach happiness, not to mention solve global warming.</p><p>There is something charming and sweet in this answer — the endless triumph of hope over experience. There is something sad in it as well. As best the sociologists and economists can ascertain, the reason we are less happy than our statistics would predict is that we are starved for human contact, for community. Starved, that is, for the chance to make ourselves a little smaller, a little less central to our lives. If you think about it, that makes a certain sense of the statistics. After all, it was the 1950’s when we isolated ourselves in the suburbs, with the first of the series of screens that now dominate our lives. We are beginning to figure that out.</p><p>Just as a small example of what might be changing, the number of farmers’ markets has doubled and then again in the last decade. It has sprung up in rich communities and in poor ones, partly because people have begun to realize the environmental benefits of local food networks (they can cut the energy intensity of your dinner, and hence its carbon emissions, by a factor of ten,) partly because people want better food that tastes like something, and partly because people want community.</p><p>A team of sociologists shadowing shoppers last year reported that those at farmers’ markets had ten times more conversations than shoppers at supermarkets. An order of magnitude less energy, an order of magnitude more community, and all with an innovation (the farmers’ market) that in technological ways of thinking is less efficient than the conventional model it replaces. Just in case you are wondering, by the way, in Europe, where such institutions are somewhat more common, and where, as I have said, people lie a little differently along the spectrum between community and individuality, life satisfaction has not decreased in the same way that it has in this nation. Food for thought.</p><p>As you can tell, I fear very much the further rationalization of our societies promised by these Singulatarian technologies. I fear very much the further extension of our hyper-individualist model. I hope very much that as democracies we can summon the will to draw on our better angels and draw the lines that might prevent their full enactment, just as in the last century we struggled to bring under workable control the possibilities represented by the smashing of the atom.</p><p>In some cases, I think it has become fairly clear where those lines should be drawn. Germline genetic manipulation, I think, should be banned. Extensions of more traditional medicines, represented by stem cell research or somatic gene therapy should be permitted, although closely monitored. In other areas (nanotechnology, say) I don’t think we know just where a wise democracy would set the boundaries yet.</p><p>Now, I understand that the very idea of boundaries intensely irritates some people, perhaps some people in this room — the idea that individual enterprise and expression might someday bow to community judgment. I know that for those who style themselves the Columbuses of these new voyages, such Flat-Earthism seems hopelessly irrational. Still, given the stakes (and as I say, I think the stakes are nothing more and nothing less than the future of human meaning) it seems to me worth taking all of this as slowly as we can, putting some breaks on what Ray Kurzweil has described with such power as the pellmell rush toward some ultimate end point.</p><p>One way to think of this is:<em> Is there some goal to our existence, some end point toward which we are heading? </em>If so, then perhaps it makes sense to speed up we will get there faster. What is it that we need all this new computer power to do, all this extra intelligence to figure out? I have tried to way the practical possibilities in cases like global warming, and I find them, as I say, dubious. In any event, my reading of this movement’s literature leaves me thinking that practical applications are a small part of the excitement — that an eschatological fervor drives a lot of this work.</p><p>Let me give you a few quotes. “It will allow us a deeper understanding of what truly we are,” says Rodney Brooks. “Our new biology,” adds <a href="http://metaverse.jeriaska.com/people/Gregory-Stock/">Gregory Stock</a>, “will allow us to pierce the veneer of inside things so that we may reach the naked soul of man.” In the words of J. Hughes, “re-engineered minds will permit us to think more profound and intense thoughts. Forgive me for saying so, but these sound like sentiments shared in the parking lot on the way out of a Phish concert.</p><p>Look, environmentalists — and I am one — may overvalue the present and under-appreciate the glories of the techno-world to come, but I don’t get it. The great Princeton geneticist <a href="http://en.wikipedia.org/wiki/Lee_M._Silver">Lee Silver</a> in the conclusion to his book <em>Remaking Eden</em> on the gen-rich future, describes the immortals that we will build with all our new technologies as as different from humans — and here he echoes Eliezer’s words — as humans are from the worms with tiny brains that first crawled along the earth’s surface. He cannot find the words to describe these celestial beings. “‘Intelligence,’” he says, “does not do justice to their cognitive abilities. ‘Knowledge’ cannot explain the depth of their understanding. ‘Power’ is not enough to describe the control they have over technologies that can be used to shape the universe in which they live.”</p><p>What do these sublime creatures do all the days of their endless lives? In his view, they dedicate their time to answering three questions. <em>Where did the universe come from? Why is there something rather than nothing? What is the meaning of conscious existence?</em> With all due respect, these strike me as profoundly uninteresting, at least concerned with the deep human questions. <em>How are you feeling? Can I give you a hand with that? Do you think you could ever love me, too?</em> It is there that I end my defense of the world we now inhabit and I thank you very much for your patience.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/508/0*pKHx_fQbQI8yiztI.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b9563248e5d0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Novel Paradigm of Longevity Science]]></title>
            <link>https://medium.com/@emergingtechnology/the-novel-paradigm-of-longevity-science-c34611545b0b?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/c34611545b0b</guid>
            <category><![CDATA[life-extension]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 08:38:34 GMT</pubDate>
            <atom:updated>2016-01-01T08:38:34.403Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/499/0*KDQsk_ixir6D8RH8.jpg" /><figcaption>Daniel Perry, Gregory Fahy and Michael West at Aging 2008 in Los Angeles</figcaption></figure><p>October 1st, 2008</p><p>Daniel Perry, Executive Director of the Alliance for Aging Research in Washington, D.C. heads the leading citizen advocacy organization in the nation, promoting a broad spectrum of research focused on improving the health and quality of life of the aging population.</p><p>Mr. Perry’s diversity of health policy, government, political and journalistic experiences make him an expert in his field. He frequently is called upon as a speaker on aging research and policy before a myriad of audiences. As a journalist, he has been widely published and was the recipient of numerous awards and citations, including a nomination for the Pulitzer Prize.</p><p>The following transcript of Daniel Perry’s presentation at the free symposium entitled Aging: The Disease, The Cure, The Implications has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FUb5UDlSp74s%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DUb5UDlSp74s&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FUb5UDlSp74s%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/9b09a447852e0854bb68645fda292eac/href">https://medium.com/media/9b09a447852e0854bb68645fda292eac/href</a></iframe><p><strong>The Novel Paradigm of Longevity Science</strong></p><p>Not long ago the editors of the journal Science put out a very special issue. They wanted to commemorate 125 years of the magazine being in publication, so the editors polled themselves and listed 125 really big questions that we do not yet have the answer to, but which are now reachable by today’s scientists.</p><p>A normal issue of Science Magazine, for those of you who subscribe, report on small things that scientists are learning about how the world works. In the case of this special commemorative issue, they wanted to list 125 things that we don’t know, but we will know or will be very close to knowing in the next 25 years.</p><p>Because 125 is still a big number and they were conscious of readers’ attention spans, they published all 125 but listed an elite 25 questions as well. These are questions like: “What is the universe made of?” and “Can the laws of physics be unified?” and “What will we find to run the world in place of cheap oil?” Big questions.</p><p>Very high up in that list of 25, big question number six that the editors of Science Magazine believe we will learn or be very close to learning in the next 25 years is the following. “How much can human lifespan be extended?” The answer to that question, as you have heard tonight and which I know is on your minds in any case, will be utterly profound.</p><p>For the past two decades I have headed the Alliance for Aging Research in Washington. We are a non-profit organization. We do engage in very spirited advocacy in the nation’s capital. We do it well in both the spirit and the letter of the law regarding the tax code. We have been called on numerous occasions to testify on Capital Hill before House and Senate committees. We maintain close ties to the executive branch, science agencies and many Capital Hill agencies. We keep busy feeding information to the authorizing, appropriating and budget committees about the value of medical research on the diseases that mostly manifest themselves after middle age.</p><p>However, I must tell you, I am constantly dogged by the question that comes from so many people: “What do we mean by ‘aging research’?” I will tell you what I tell them. First of all, I assure you that the Alliance for Aging Research is not an advocacy group for research that is getting really old and out of date. When I explain to them that we are advocates for science with the potential to improve and add years of health and vitality for millions, there is still another set of questions.</p><p>Are we talking about research into specific diseases of aging? Cancer, Parkinson’s, cardiovascular disease? Are we talking about getting the nation’s health professional workforce ready to meet the coming silver tsunami of chronic age-related diseases? Are we talking about general wellbeing and nutrition, psychological adjustment and wellness for people at later life?</p><p>In some sense the answer is: “All of the above.” What I want to focus on in the time that remains is the question that for many of us now seems to be the most intriguing of all — the one question with the potential to change everything we think we know about aging and longevity. What can our very best scientists learn about the fundamental biological mechanisms that we call the aging process? What are the chances that we will use that knowledge of the underlying process to our own benefit?</p><p>This is the dominion that we call biogerontology. Success in this realm would be the most consequential and indeed the most disruptive technology we can imagine. Success could redefine the length and quality of human life beyond anything we know. The greatest value of all that might come from biogerontology is that it might provide us with a strategy for preventing, postponing, or even eliminating many current diseases of aging.</p><p>Scientists have shown in many experiments that aging can be slowed, put on hold, even in some cases reversed in laboratory animals. Here is the best part — those interventions in aging with test animals act as a powerful means to put off, prevent, or at least postpone a large number of health catastrophes that can accompany aging: everything from cognition and organ failure to blindness and cancer. Many of you have read about caloric restriction. There are also hormonal manipulation and genetic interventions in test animals. The way age delay works is by putting all of those diseases much later in life and closer to death — the compression of morbidity that <a href="http://metaverse.jeriaska.com/people/Gregory-Stock">Dr. Stock</a> mentioned.</p><p>Ironically, for all of the potential good that could come from biogerontology, here is the bad news. It has been examined and analyzed less than almost any other field of medicine by policymakers and by the media. It has received less support from government, industry or private philanthropy. Even if we were to be successful, modifications in aging could so challenge fundamental beliefs of people so as to incite irrational fears and resistance from the very people it would help.</p><p>A couple of years ago, Dr. <a href="http://pimm.wordpress.com/2006/11/28/moderate-life-extension-yes-maximum-no-interview-with-huber-warner/">Huber Warner</a>, who spent 21 years heading the smallish biology of aging program at the National Institute on Aging went back to academia, and he wrote “Compared to other medical disciplines, the work on biomedical gerontology has been poorly regarded and under-funded during the last half of the 20th century.” That is true enough.</p><p>Now, consider this statement from a forthcoming paper that will be published in the next few weeks by the <a href="http://www.bmj.com/">British Medical Journal</a>. It is authored by a dozen leading American and British scientists, including two former directors of the National Institute on Aging. Here is a statement from that article:</p><p>“There is now reason to believe a new paradigm of health promotion and disease prevention for the 21st century is plausible and will include as its central theme a concerted effort to slow aging in people. Such an effort, if successful, will serve as a new broad spectrum strategy of primary prevention that would significantly enhance and accelerate improvements in health at all ages.”</p><p>That is what is coming out from very highly regarded and mainstream scientists on two continents. It is pretty expansive and forward thinking. What can each of us do to advance a new paradigm for health promotion and disease prevention in the 21st century that makes as its central tenet the slowing of aging?</p><p>Recently, the board of directors of my own organization, which includes Bill Haseltine, committed to an aggressive effort to speak out for longevity science, which I think is a more elegant way of saying biogerontology, in order to hasten the social benefits extending healthy aging, a goal that we have referred to as “pursuing the longevity dividend.”</p><p>Now, the members of my board are not naïve. They know very well that longevity science continues to be a tough sell. Let’s face it, call it by any name, the quest for significantly extended lifespan has an image problem, as <a href="http://www.acceleratingfuture.com/people/Gregory-Stock%27">Dr. Stock</a> mentioned. For well over the past millennium of human history, we have heard plenty about searches after the philosopher’s stone, or the fountain of youth, or the elixir of life. People know that such quests have been notoriously unsuccessful in the past.</p><p>By now perceptions of those quixotic journeys are so deeply engrained in our cultural consciousness. Then again, the medieval alchemists and Ponce de León did not have the tools of nanotechnology or the knowledge of the insulin signaling pathway to guide them. They did not have proteomics or the human genome to work on. In the 21st century, we either do have or soon will have a much stronger grasp on all of those technologies.</p><p>Ultimately, success against the pathologies of aging will come from the applications of really, truly big science. This will be a combination of biological insights, incredibly high speed information systems, statistical modeling and systems engineering. Here in California, we keep coming back to this, also in the United Kingdom, Singapore, Israel and Japan, these technologies are already being put to use to unlock the potential of regenerative medicine. Indeed, regenerative medicine, stem cell research, and related technologies might very well be the critical enabling platform for an early stage of longevity science.</p><p>Large sums from private philanthropy certainly have an opportunity to lead the way, especially in the early stages, to overcome the disbelief and the inertia found at the governmental level. Ultimately, big science on this scale will require the resources, leadership and commitment of national policymakers. I must tell you, tonight we are not there.</p><p>Most politicians are not biologists. They are not biotech entrepreneurs. Most of them are lawyers, and unlike Bernie Siegel, they are insecure when it comes to talking about science and medical matters. Sure, they will launch a war on cancer or a war on AIDS, but they will only do that when their insecurities are first overcome by established medical figures. They are not going to stick their necks out into something that does not already have luminaries from Harvard and MIT paving the way for them.</p><p>Unfortunately, most of these established medical research authorities have made their careers pursuing medical goals not globally aimed at aging, but one disease at a time. That is how we award Nobel Prizes, by following a particular pathway. Going after aging, and the complexity of that, is not the way the medical authorities earn their stripes.</p><p>Most established scientific leaders have been brought up to believe that aging is not only unchangeable, but not even very interesting. Now let’s move to lay people. Most of them think there is not anything you can do about aging. Go out to West Covina and ask people if there is anything you can do about it. They believe that even if you could, it would be a social and an economic catastrophe. Too many sick, old people sitting around, not pulling their weight. Even if people believed there could be some scientific breakthrough that would make it possible to extend the healthy years of life, many will set themselves up in opposition because it sounds unnatural or upsetting to social norms or religious beliefs.</p><p>Then there are those who believe there is something that you can do about aging, and in fact, it is already possible by way of the nutritional supplements you order online or buy at the GNC stores. They say, “Who needs further research?”</p><p>What will it take to overcome negative assumptions among the public? What will it take to convince cautious public officials to set up the kind of major scientific effort to crack the biology of aging. US health expenditures will be three trillion dollars before even the oldest Baby Boomer turns 65 and joins Medicare in less than three years. Three quarters of this national health bill goes to treat chronic diseases, most of which are driven by the underlying processes of aging–cardiovascular disease and stroke, Type II diabetes, neurodegenerative diseases, cancer, loss of vision and hearing… the list goes on and on. Just four diseases alone already account for nearly one trillion dollars in health expenditures in the United States each year.</p><p>By 2030, Alzheimer’s disease alone will cost one trillion dollars a year. That is the equivalent of the entire Medicare budget, Medicaid, and veteran’s benefits going toward one disease by 2030.</p><p>If you want to get the attention of national policymakers, you want to remind them of this rolling horror show of chronic diseases, disability, lost human potential and the almost unimaginable costs to budgets at the federal, state and county level. Next, we need to drive home the message of biogerontology and bring the authorities together to make it stick. Some control over the processes of human aging may be the only way to blunt the impact of the multiple diseases of aging, that we call the silver tsunami, headed our way.</p><p>Compelling scientific evidence that it is indeed plausible to delay, postpone or modify diseases of aging in our species — that point has to be made beyond doubt or dispute. To prove our case, we are going to need credible and statistically validated measures that track the slowing of the aging process. In drug development, these are called biomarkers. Today the FDA does not recognize that there is anything that will change these variables of aging. Until there is some level of scientific consensus to convince the FDA that a drug that comes into the pipeline will get an approval because it is retarding a multiple number of measures of aging, this will be an underfunded area in terms of industrial investment.</p><p>Imagine what would happen if there was some level of recognition that if you hit these fifteen different data points in a clinical trial, you get a label that says you are an age-retarding medication. It may be that the first one that comes through that pipeline will be aimed at a specific disease like diabetes or metabolic syndrome, but it is working because it is affecting the underlying biological mechanisms of aging. After a few years there are more scientific papers saying the people on this diabetes medication are getting fewer heart attacks, strokes or cataracts, pretty soon there is off-label prescribing of this drug. That may be another way in which the first anti-aging therapies make it.</p><p>It also might be a huge psychological breakthrough if an animal study such as the Methuselah Mouse Prize shows that instead of dying at three or four years, somebody has engineered the same species of mouse to live six or seven years. There are a number of ways we might be able to make that kind of breakthrough. One thing that I know we can do right now to try to prepare policymakers, and indeed the entire public, to accept, anticipate and yearn for an advance is to explode the myth that success in longevity science is going to mean more sick old people and a drag on the economy.</p><p>We are looking for ways to fund a series of high level papers from the world’s most prominent health economists to show that all things considered, extending the healthy years of life, even with higher costs in some areas, will be a boost to our economy that will be beyond what anyone can imagine. That is something that we can do, and we are hoping to do it very soon.</p><p>Finally, policymakers need to see that we are already spending tens of billions of dollars every year on the National Institutes on Aging on a limited and possibly flawed strategy of going after one disease at a time. Because in old age there is so much co-morbidity, even if you were able to nail stroke or even some cancers, there is so much co-morbidity that you never get out of the box. In fact, trying to fund medical research in the diseases of aging one at a time is a little bit like carrying water in a paper bag that is leaking in many different slits.</p><p>The longevity science answer is to preserve the overall integrity of the paper bag, despite time, wear and tear. In the aging analogy, the key to that stronger bag is understanding the underlying mechanisms of aging and pursuing that knowledge to its ultimate goal, which would be a broad and beneficial longevity dividend for our entire society.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c34611545b0b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Delaying the Degenerative Disease of Aging]]></title>
            <link>https://medium.com/@emergingtechnology/delaying-the-degenerative-disease-of-aging-a1b4ab77b060?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/a1b4ab77b060</guid>
            <category><![CDATA[life-extension]]></category>
            <category><![CDATA[bruce-ames]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 08:34:25 GMT</pubDate>
            <atom:updated>2016-01-01T08:34:25.069Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*LCNWvjWKXBpkH89G.jpg" /><figcaption><em>Marisol Corral-Debrinski and Bruce Ames at Aging 2008</em></figcaption></figure><p>October 1st, 2008</p><p>Bruce Ames is a professor of Biochemistry and Molecular Biology at the University of California, Berkeley, and a senior scientist at Children’s Hospital Oakland Research Institute (CHORI). He is the inventor of the Ames test, a system for easily and cheaply testing the mutagenicity of compounds. His research focuses on cancer and aging and he has authored over 500 scientific publications. He is among the few hundred most-cited scientists in all fields.</p><p>The following transcript of Bruce Ame’s presentation at the free symposium entitled Aging: The Disease, The Cure, The Implications has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FBHzofN63MvU%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DBHzofN63MvU&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FBHzofN63MvU%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/780e08d3ca49cb13ede92567bdf6af64/href">https://medium.com/media/780e08d3ca49cb13ede92567bdf6af64/href</a></iframe><p><strong>Delaying the Degenerative Disease of Aging</strong></p><p>I would like to tell you about two areas of research we have been doing on aging and why I think that both are going to lead to delaying aging. The first is mitochondrial decay. My interest is preventative medicine. I worked on DNA damage, its relation to cancer, and how to delay it. I realized that cancer was one of the degenerative diseases of aging, along with heart disease and brain dysfunction, all the things you learn about soon enough.</p><p>I got interested in aging, and a postdoc came to by lab who knew about mitochondria. If you read the literature you know that there is a lot of circumstantial evidence suggesting that mitochondria decay, and that is contributing to a lot of aging. There are about 500 mitochondria per cell. It is the most complicated organelle in the cell. Basically they are burning your fuel, fat and carbohydrate.</p><p>“Burning” means taking electrons from them. If you add four electrons to oxygen, which is the electron-acceptor (all the oxygen you are breathing goes through the mitochondria) and that process creates ATP, which powers your muscles, your brain and your metabolism. You make kilos of ATP everyday. We ran tests on aging in rats and mice. We decided we would work on mitochondrial decay and determine to what extent that is contributing to aging and how we could manipulate it without waiting two years for the rat to get old.</p><p>All of life is trade-offs. You are adding four electrons to oxygen. If you add them one at a time, you are adding all these oxidants. That is an inevitable byproduct of living. Nature is better than most engineers — it is 98 or 99% efficient, but as you get older the mitochondria are putting out more oxidants. It is like an old car engine that has less efficiency and more black smoke.</p><p>We set out to compare mitochondria from old rats and young rats and try interventions. We tried lots of things and found two substances that would delay all the assay from mitochondrial decay that we had set up. We had set up four different areas of mitochondrial function that were known to decay with age. Between these two substances, it delayed these.</p><p>This is a blow-up of mitochondria. As I said, there are about 500 per cell. It makes all the energy in the cell. There is an outer-membrane, an inner-membrane, and inside the mitochondria. This membrane potential across this inner-membrane drives Complex V here to make ATP, the chemical energy of the body.</p><p>Basically, mitochondria recharge old batteries. What this burning process does is it moves electrons across these complexes. Each of these complexes have hundreds of proteins. A thousand proteins get shipped in from the nucleus and into the mitochondria. The mitochondria have their own piece of DNA and they make a few proteins. It is all very complicated and lots of Nobel Prizes have been awarded for the people who figured all this out. Basically, this process pumps protons across the mitochondrial membrane, and that charge across the membrane drives Complex V.</p><p>The two compounds we came up with were acetyl carnitine, which is a normal mitochondrial metabolite, and lipoic acid. We were feeding them much higher levels than you can normally get in food, and they worked. It made old mitochondria look more like young mitochondria. We tested aspects of brain function in rats, mice and dogs, and it worked. The university of California took out a patent on this combination. It is called <a href="http://juvenon.com/">Juvenon</a> and is sold over the web. I founded a company and put all the stock in a foundation so that I have no financial interest, but the money is all going to go to science. The company is selling lots of these pills, the money goes into clinical trials. I am quite excited about that.</p><p>Complex IV decay contributes to Alzheimers, Complex I decay contributes to Parkinson’s, and more and more diseases of aging are being traced to mitochondrial decay, though it is not the whole story.</p><p>That is all I am going to say about that area because it was published awhile back, but I want to tell you about my new enthusiasm. You are all aging yourself faster, and I would like to tell you how to avoid that. Half the world is aging themselves faster by eating lousy diets. This shows metabolism:</p><p>What do you need to run your metabolism? You need energy, and you get that by burning your fat and carbohydrate, but you need something else. You need about forty micronutrients from food. Metabolism requires fifteen minerals including iron, magnesium, manganese, calcium, and copper. You need about fifteen vitamins, and those become coenzymes or hormones. Then you need two essential fatty acids, omega 3s and omega 6s. Then you need about eight essential amino acids. If you do not get any one of those, you will die, so you need to be eating a balanced diet.</p><p>Over the past fifty years nutritionists and biochemists figured out we need niacin, which becomes an important coenzyme used in hundreds of enzymes. British sailors on long ocean voyages, a third of them would die, their teeth would fall out and get scurvy. Then they found out that if they took limes on the voyages and ate lots of limes, then they did not get scurvy, so the British sailors were called “limeys.” Then, vitamin C was isolated.</p><p>We have eliminated mostly rickets, scurvy and berriberri, these diseases that come from vitamin deficiency. Yet we are not eating what the committees think we ought to be eating. Recommended dietary allowances (RDA) is what the committees say we should be getting for each of those. Two standard deviations below that is something called the EAR, but nobody gives a damn because there is no pathology associated with it. What I am going to tell you is I think I know what the pathology is. Being low in one of these micronutrients ages you faster.</p><p>The argument is that throughout all of evolution, animals were running out of one micronutrient or another — fifteen minerals are not spread evenly in the world. Animals are running out of magnesium or iron. What does nature want to do when you are running out of magnesium? It cuts out any metabolism that is long-term. DNA damage shows up as cancer five years down the road? The hell with it. Your adaptive immunity leads to dying of a more severe infection five years down the road? The hell with it. Your mitochondria put out more oxygen radicals, so you have Parkinson’s or Alzheimer’s? The hell with it. Basically you are paring down to what is vital so you can reproduce a little bit. That’s what nature cares about.</p><p>That is the argument: I call it triage. The first iteration of this was published a couple years ago. We keep on finding one example after another, and we are in the middle of trying to test it in people. The pathology is all insidious — it is the very things that happen with aging. DNA damage goes up with aging, your adaptive immunity goes out with aging, your mitochondria put out more oxygen radicals with aging, and that is what is accelerated by micronutrient deficiency.</p><p>That is the argument. I’m a bit of a visionary, so you don’t have to believe it all, but I am going to try to prove to the scientific community in the years I have left to do science that all this is true.</p><p>This shows what percent of the population is below the EAR. The EAR is where the committees put a red flag if you are not getting enough. Menstruating women are losing iron. 16% are below the EAR for iron. All kinds of nasty things happen when you are anemic. For magnesium, 56% of the US population is below.</p><p>What is going on here? Where do you get magnesium? It’s in the center of the chlorophyll molecule. If you eat anything green, you are getting magnesium. The main source is green things. You eat a big plate of spinach, you are getting a healthy dose of magnesium. The body wants two calciums to one magnesium, but we are dreadfully short of magnesiums because people aren’t eating their greens. You get a little from whole grains, and people are not eating a lot of whole grains either.</p><p>Zinc is very important. There are hundreds of enzymes with zinc fingers that are turning on and off things. You make a cell a little zinc-deficient and you knock out all these things. Practically everyone is low on vitamin E. Half the population is low on Omega 3 fatty acids. You start adding all of this up and you wonder whether anyone besides Walter Willett is eating a perfect diet–he is the leading epidemiologist on nutrition.</p><p>Now, are we talking about 10% of the population, or are we talking about 80% of the population? My own guess is it is going to be a sizable percent of the population — all the poor and all the obese. The obese are eating sugary soft drinks and donuts and they think they are hungry all the time because their body is craving that missing magnesium.</p><p>I first got onto this when a geneticist named Jim MacGregor came to my lab on sabbatical. He had just stumbled on the fact that folic acid deficiency breaks your chromosomes. Folia is the latin word for leaf — foliage. My mentor at Caltech, where I got my PhD back in the early ’50s, was Herschel Mitchell, and he first isolated folic acid from four tons of spinach. If you don’t eat your greens, you are not getting folic acid. If you don’t have enough folic acid, you start putting uracil in your somatic cell DNA and in your sperm, so you are making nicks and breaks in your own DNA, just like getting irradiated.</p><p>MacGregor started looking in people, and this is the baseline for chromosome breaks. When I looked at what percent of people were at the level of folic acid deficiency where it was breaking chromosomes, it was half the poor.</p><p>Here is a comparison of X-rays and folic acid. We looked at iron. Too much iron — that’s men eating too much meat. Two billion women and children were not getting enough iron. Too much or too little iron wrecks your mitochondria. If you want to age yourself faster, just eat low iron. Mae West said too much of a good thing is wonderful, but I think she was thinking about sex, not micronutrients. You don’t want to overdo things.</p><p>Mouse pups who are low on iron don’t do well on IQ tests, and the rat pups don’t do well on rat IQ tests, and kids don’t do well in school if they didn’t get enough iron. The brain is a trillion neurons and a thousand connections each. You don’t get a good diet and your brain is not functioning well.</p><p>We started looking at many micronutrients, and in every case we found DNA damage. I thought, why the hell is nature doing that? It had to do with mitochondria pouring out more oxygen radicals. This shows a cell that is biotin deficient and it just fills up with oxygen. The mitochondria pour out oxygen, just like they were old.</p><p>I looked up on the web, and you find all kinds of micronutrient deficiencies that are associated with chromosome breaks or cancer, but epidemiology in people is a very iffy science. The epidemiology joke is, “Miami is a weird place. Everybody is born Hispanic and dies Jewish.”</p><p>The first iteration of my paper on triage, I call it, argues that the pathology associated with low micronutrient intake is aging you faster. This came out two years ago, and now we are working on the second iteration. It is not just DNA damage and your mitochondria pouring out oxygen radicals, it’s your immune system. If you look at what goes wrong with the immune system with aging, there are six things that go wrong. If you look up has anyone ever looked at this versus micronutrient deficiency, the literature is out there and we keep on finding more examples.</p><p>I think all aspects of your aging are going faster. Just to finish up, many years ago we published a paper that folate deficiency knocked out your CD8s relative to your CD4s. I didn’t understand it, but we published it. Now I understand it, because it is one of the things that goes out with aging in the immune system and when you are short on micronutrients.</p><p>This says, “You’re fifty-seven years old. I’d like to get that down a bit.” I think, if all this is true, we are talking about half the world. Micronutrients are dirt cheap. It’s what your mom said. Eat your veggies, eat a good, balanced diet, and take a multivitamin as insurance. You don’t get all the micronutrients from the multivitamin. You need Omega 3s, which you get from deep sea fish. You need magnesium, calcium and potassium, which would make the multivitamin way too big, so you need to be sure you are getting those things. But don’t overdo it.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a1b4ab77b060" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Advancing Stem Cell Research]]></title>
            <link>https://medium.com/@emergingtechnology/advancing-stem-cell-research-bf690788519f?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/bf690788519f</guid>
            <category><![CDATA[life-extension]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 08:16:21 GMT</pubDate>
            <atom:updated>2016-01-01T08:16:21.617Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/496/0*LwJnkAIz2e51TAWL.png" /></figure><p>September 30th, 2008</p><p>Bernard Siegel is the full-time Executive Director of the nonprofit Genetics Policy Institute (GPI) based in Palm Beach Gardens, Florida. In 2002, Mr. Siegel filed the landmark case seeking a guardian for the alleged clone, “Baby Eve.” The case was widely credited for exposing Clonaid, the so-called “human cloning company” as a sham.</p><p>In 2003, he traded his 30-year courtroom career to found GPI, which leads the global cause in support of stem cell research. He is a recognized policy expert relating to stem cell research, regenerative medicine and cloning. He also works with grassroots activists throughout the United States, educating lawmakers and formulating effective strategies supporting research for cures.</p><p>The following transcript of Daniel Perry’s presentation at the free symposium entitled Aging: The Disease, The Cure, The Implications has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FQp2a3xrW_UE%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DQp2a3xrW_UE&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FQp2a3xrW_UE%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/2404c3e7ef1580862cfff31e7ecf7435/href">https://medium.com/media/2404c3e7ef1580862cfff31e7ecf7435/href</a></iframe><p><strong>Advancing Stem Cell Research</strong></p><p>I was an attorney in Miami, Florida at the end of 2002. Watching television, I saw CNN break in live. That was Dr. Boisselier of the so-called human cloning company Clonaid, part of the Raellian UFO sect. I don’t know if there are any followers of Rael here, if you would raise your hand? I was watching this and the world seemed to come apart. The zeitgeist at the time was that reproductive cloning was just around the corner. Dolly the sheep was in 1997, there had been articles in Wired talking about IVF doctors playing with cells in their back room, and that this was something that we had to fear.</p><p>As I watched this, I remembered that I had helped my daughter with a paper on Dolly the sheep in junior high school, and I knew that you could not clone a person safely. It was not a safe thing to do, it was not ethical, and as I observed the world coming unglued as to whether this happened, I said to myself, “You know, I could do something about this.” Anyone who is aware of a child who is potentially neglected or endangered in some way could file a petition with the court, and I was right in Miami, so I drove up on December 31st, 2002 with a petition I had typed up, seeking a temporary guardian for the alleged cloned child, thinking to myself that perhaps this would be a footnote in some law journal.</p><p>That night I went home, turned on CNN, my wife and I were not going out until later. Across the bottom of the ticker it said “Florida attorney Bernard Siegel seeks custody of cloned baby.” My wife turned to me and said, “Bernie, what did you do?” This was the case that Connie Chung described as the most unusual case in human history. A couple nights later I got a call from a reporter saying, “Mr. Siegel, do you have a comment? Rael has said they are not going to do the DNA testing because you are trying to take the baby away from the mother.”</p><p>Two nights after that, I was debating Rael on Connie Chung Live. There, Connie Chung asked the most unusual question ever asked on television. She said, “Your holiness, how is the world to think that you are anything but a megalomaniac, having sex with your followers and doing this for publicity?” And he says in a French accent, “You wouldn’t talk this way to the Catholic Pope,” and I’m looking at the monitor thinking to myself five days ago I was an ordinary attorney, now I’m debating a deity on world television.</p><p>It turned into a serious matter. It became a real case and a big media <em>cause célèbre.</em> In thirty days we were able to put a pin in this, and found out that Clonaid lacked a street address, lacked a board of directors, and was nothing more than a sham. Even though Brigitte Boisselier went to court and said there was a cloned baby, it was born in Israel and had never been in Florida, and therefore no jurisdiction, it was widely recognized that this was just a publicity stunt.</p><p>I was so amazed as I did the research and was faced by searing media scrutiny as to why I intervened in this. As a cancer survivor myself, it was very significant to me that this group had testified in congress, appeared before the national academy of sciences and were impacting the public perception about stem cell research — stem cell research being one of the core technologies for anti-aging.</p><p>As I delved into it, who was foisting these people on the public and why were they taking it seriously? Two prominent scientists, Rudolph Jaenisch at MIT and Ian Wilmut, the father of Dolly the sheep, reached out to me and said, “You were the only person to stand up against these cartoon scientists. Thank you for doing that. If you will create an organization to advance the cause of scientific research and perhaps be a legal mouthpiece for this, we will introduce you to the scientific community.”</p><p>If you go to Fox News, CNN or MSNBC, in a minute you might have a legitimate scientist and a charlatan. How is the public to understand, with our tenth grade biology educations, who is telling the truth and who is not? When on August 1st, 2001, President Bush gave his first speech to the American public, it was on the subject of stem cell research. Of course, he placed an arbitrary line in the sand. He created limited funding for embryonic stem cell research, only for those stem cell lines that had been created before that date in time.</p><p>That is about 22 stem cell lines, which frankly are not enough. Indeed, since that announcement approximately $160 million of federal funds from NIH have gone into research on these federally funded embryonic stem cell lines. How significant is that? $160 million, what is that, a half hour in Iraq? It is a drop in the bucket compared with the $28 billion NIH budget. Indeed, Irv Weissman, the preeminent stem cell scientist at Stanford, has said that the NIH is perhaps the greatest engine of scientific advancement in the history of man, and we find that the NIH is basically on the sidelines of this incredible field of regenerative medicine.</p><p>I was very concerned with who is trying to limit this. Of course, you need to know that the same sources that have limited funding for this field are still active today. Much of this in this country comes from the religious right, of course. <a href="http://en.wikipedia.org/wiki/Roe_v._Wade">Roe v. Wade</a> decided in the 1970’s based on a woman’s right to privacy, deciding first trimester abortions are allowed. The forces against that have been roiling up in American politics for years.</p><p>The funding for this fight against embryonic stem cell research can be found in the funding for social conservative think tanks. Approximately $162 million a year, according to a study by the <a href="http://www.womensbioethics.org/">Women’s Bioethics Project</a>, is poured into enterprises like the <a href="http://www.aei.org/">American Enterprise Institute</a>, the <a href="http://www.discovery.org/">Discovery Institute</a>, <a href="http://www.focusonthefamily.com/">Dr. Dobson’s Focus on the Family</a>, and the <a href="http://www.frc.org/">Family Research Council</a>. These organizations have a bioethics agenda as part of their platform. They spin out the message box that is going against this research, a message box that might say we don’t need embryonic stem cell research because adult stem cell research works.</p><p>In the years that I have been doing this, and I gave up the practice of law to do this, it has been a challenge to debate many of these foes of stem cell research at different platforms. I remember debating Dr. <a href="http://www.frc.org/get.cfm?i=BY04H12">David Prentice</a> of the Family Research Council. He throws up a slide of a football scoreboard, and it would say “Adult Stem Cell Research: 72, Embryonic Stem Cell Research: 00.” They are trying to say that there are seventy-two cures coming from adult stem cell research, and that embryonic stem cell research is nothing more than junk science. Well, that is ridiculous, of course. Since Jaime Thompson’s incredible experiment in 1998, we have only begun our research in this breathtaking area. Of course, we are still a distance from clinical trials, but we are actually talking with the FDA now about clinical trials.</p><p>To try to say that there has been no progress in this field ignores the scientific method and all the work that has been done successfully with animal models. They will foist ideas like there are snowflake babies, as if there are thousands and thousands of people ready to adopt frozen embryos that are going to be discarded. Maybe there have been eighty cases of that, and there are 400,000 frozen embryos, many of which can be donated to science. This is a resource that is necessary if we are going to advance this research.</p><p>These forces like to wield the term “human dignity” in a coercive way. Who are these forces? These are the same folks, historically, that thrust Galileo into the Inquisition, they burnt Bruno at the stake, they fought inoculation, surgery and anatomy. These are the same social forces that are out there today, trying to keep this in the bottle. They are worried about the societal implications of biotechnology. Indeed, if you look at our culture and you talk about the zeitgeist, look at the movies like “I am Legend,” or any number of movies, there is this fear of biotechnology. The forces that are trying to hold this back are tapping into this fear all the time.</p><p>In my view, society has a way of dealing with these fears. There will be a time when aging is defeated. There are going to be a lot of legal ramifications to that. What are you going to do with sentencing when someone commits a crime if they could live for 150 years or more? There will be a new meaning for permanent alimony, won’t there?</p><p>The law works in incremental ways. While there is a debate over embryos and where life begins, foes of research will look at cells in a Petri dish and see them as people. The law has to deal with issues like this all the time. Right now there are cases in the United States where they are fighting over custody of frozen embryos in a dish. When they are fighting over this, they are not thinking of the best interest of the embryo. The best interest of the child is the test. In every case they look at these cells as personal property. Society has a way of dealing with these issues, and certainly it will if we are able to advance the human lifespan.</p><p>I want to share with you a couple of other things. You hear the issue of cloning coming up. There is reproductive cloning of a baby, and everyone basically is opposed to that. They can see that as being an unsafe practice. However, there is also therapeutic cloning of cells, or nuclear transfer. The foes of stem cell research have gone so overboard that they have actually built the movement that is fighting these advancements in a big way.</p><p>You look at Senator <a href="http://brownback.senate.gov/">Sam Brownback</a>, the conservative senator from Kansas, and we call it the Brownback Bill. This bill would incarcerate a scientist for ten years if he engaged in therapeutic cloning, a form of stem cell research. Indeed, if a patient went overseas and took some therapy, upon reentry into the United States that patient would go to jail for ten years or face a million dollar fine. It is even more stringent in Michigan. These fights are going on state by state all over the country. There is an initiative in Colorado to define personhood at conception. Could you imagine the chaos that would ensue if that passes? Every year, in every state legislature, bills are dreamed up to put roadblocks in the way of where we have to go to advance this.</p><p>Even in the United Nations, where my organization had its first success, there was a gambit backed by the Bush Administration to enact a world treaty to ban therapeutic cloning. We were the whistleblowers in that situation and we organized 35,000 FAX letters to the UN. We made a tremendous outcry, joined by scientists and the <a href="http://metaverse.jeriaska.com/2008/09/advancing-stem-cell-research/www.camradvocacy.org/">Coalition for the Advancement of Medical Research</a> then led by Dan Perry. We actually went into the United Nations and fought this issue, and eventually derailed that treaty, at first by a single vote.</p><p>The foes of freedom of scientific research are going to be with us for a long, long time. That is not going to disappear. We, as an informed citizenry, know that there have to be boundaries on science. There is a place to put our fences, but let’s put those fences in a place to alleviate human suffering and to advance the human lifespan.</p><p>I want to share one final thought with you. The proponents of life extension and folks that want to cure aging, it cannot be a narcissistic project. This has to be, at its core, an effort to alleviate human suffering. What is the pro-cures movement? It is not a political movement. It is akin to a consumer movement. If you ask a man or woman in the street right now if they support stem cell research, 70% will say that they do. Well, it is not because they see it as some giant public health issue–they see it as a personal health issue, an issue impacting their lives. That is the force that passed Prop 71, which was not a waste at all. Right now, under the current policies, I could not use a pipette from NIH funding on a non-approved stem cell line or my entire institution could lose funding. That is how outrageous the state of the law is right now.</p><p>When the Brownbacks of the world want to throw scientists in jail, that enraged certain people that had children with diabetes. Movie producers and mortgage brokers got together and created Prop 71. California leads the way with $300 billion for this research. When you compare that with the paltry amount that has come from the federal government, it is absolutely extraordinary. That is why in California and Missouri, the bellwether state, stem cell research is written in as a fundamental right in the state constitution. That is what the pro-cures movement is. If the field of anti-aging is really going to advance, if, as Greg says, we are really going to make this a Manhattan Project, that movement has to align itself and realize that we are all stakeholders in fighting for these core technologies. Thank you.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*NJaeVKtOImwRexNX.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bf690788519f" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Growing Field of Regenerative Medicine]]></title>
            <link>https://medium.com/@emergingtechnology/the-growing-field-of-regenerative-medicine-8658ea84ffa5?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/8658ea84ffa5</guid>
            <category><![CDATA[life-extension]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 07:48:01 GMT</pubDate>
            <atom:updated>2016-01-01T07:48:01.324Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/499/0*cYxCKljJtW3i7NGA.png" /></figure><p>September 28th, 2008</p><p>William Haseltine has an active career in both science and business. He was a professor at Harvard Medical School from 1976–1993 where he was the chair of two academic research departments.</p><p>He is well known for his pioneering work on cancer and HIV/AIDS. He is the Founder of Human Genome Sciences, Inc and served as the Chairman and CEO of the Company until 2004. He is also the founder of seven other successful biotechnology companies. He serves as an advisor to CMEA, a venture capital company, and to several biotechnology and pharmaceutical companies.</p><p>The following transcript of William Haseltine’s presentation at the free symposium entitled Aging: The Disease, The Cure, The Implications has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FvoZC0EX7v2M%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DvoZC0EX7v2M&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FvoZC0EX7v2M%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/6a012204d03ca3baa3091547c03d9bc0/href">https://medium.com/media/6a012204d03ca3baa3091547c03d9bc0/href</a></iframe><p><strong>The Growing Field of Regenerative Medicine</strong></p><p>It is a great pleasure to be addressing a general audience. I hope as the evening progresses, you are able to ask us questions either from the floor or over dinner. It is one of the great pleasures to hear what people who are outside of the scientific disciplines think about what it is that we are doing.</p><p>The basic problem that we all have is that we know that we are born, we grow, we live, we die. The first three of those is fine; the last we would like to avoid. Is it possible? In that statement “we are born, we grow, we live, we die,” is a paradox. That is that every generation renews itself. A 35 year-old couple will have a zero year-old baby. The fundamental nature of life is regeneration through generations. It is immortality. What we have come to understand about life is that it is based on a molecule, DNA, that contains the information that specifies what we are to become — whether a human, a tree or an insect.</p><p>Over time the ideas that have been deduced about the nature of DNA, how ancient it is, how it is related in one organism to another, have become clarified with great specificity. We can now say with great assurance something that was only speculated some time ago, that the DNA molecule that is in you, me and all living things is a living fossil that is about three and a half to four billion years-old. It is a single molecule that has reproduced itself through time in what is near immortality.</p><p>Certainly as we look at our own lifespan, three and a half to four billion years is closer to immortality than we can even contemplate. It is that fundamental nature of life, its ability to reproduce itself over time, to renew itself from generation to generation, that gives us confidence that it will eventually be possible to attach an individual life to that fundamental immortality of our DNA.</p><p>Many of us have been working in this field for a number of years. About ten years ago I coined a term — regenerative medicine. The concept was a relatively simple one. What collection of medical technologies existing today can we imagine in the future would allow us to attach our individual self to the immortality of our DNA? There were many that were possible. Some were beginning to come into view as realities.</p><p>Let me give you one of the breakthroughs that gave us some hope at that time. That was the advent of human stem cell cloning. As you have read, and as you know living here in California, we are now able to, from a single cell which can be propagated and grown, to create the essence of our reproductive immortality. That is, a seed of a human being that has the potential to be all of our cells.</p><p>It was that breakthrough that gave most of us hope that someday we would be able to take those cells and replace our parts, one by one. We know that we have the capacity for many years to renew our bodies. All of us in this room have renewed the cells of our bodies several times over. The very material that you are made of is not the material that was with you ten or fifteen years ago. It is entirely different chemicals and it is mostly different cells.</p><p>We do renew ourselves. As Aubrey pointed out, something goes amiss over time. We are beginning to have many specific ideas about what that is. We can begin to measure those processes, but to measure those processes is not necessarily to change them. What can change them is replacement of those regenerative cells.</p><p>Ten years ago, when we began thinking about this field in much more detail, assembling pretty much the group you see here on the stage and others, we had several major problems ahead of us. We knew that somehow you could take an old nucleus, the cells and DNA from an older person, put it into an egg, and something in that environment would reset its genetic clock. This is just as when the sperm combines with the egg, the genetic clock is reset, and a zero year-old child is born from an older person.</p><p>It was clear at that time that with enough effort, we would be able to do that at will — to take any of our cells, and with the right genetic manipulation, reset its clock. We could begin to use our own cells for that purpose. What was not clear ten years ago was how long that process would take. Today I am very pleased to tell you that we now have that ability.</p><p>About a year and a half ago it was discovered that a very simple procedure can take any one of your cells–possibly any cell in your body–do a minor manipulation, and turn that into the equivalent of a zero year-old fertilized egg. If you do it in a mouse, you know it has that capacity, because you can do that manipulation on a single cell in a mouse, implant it in the uterus of an animal, and a functional, long-lived normal animal will result. That means we truly have the ability to create your individual stem cells without going through the process of embryonic cloning.</p><p>That is step one. What is also clear is that although there was the potential to take an egglike cell, and it could on its own assemble a complete animal and probably a complete human being, we had no idea of how to get it to do it on our command to build a precursor for a skin cell, to build a precursor for a muscle cell. It was very much left to chance. That too is changing very rapidly.</p><p>The confidence that we have gotten from the simple observation that you can take a normal cell, even an aged cell, and reset its genetic clock, has given us the confidence to say that we can now reach into any cell and change it at will to the program that we want. We can take one of these cells–learning about what a heart muscle cell does, about what a pancreatic cell that produces insulin does–reach in and change that in such a way that we can use it to rebuild our own bodies.</p><p>Again, just in the last year, there have been fundamental breakthroughs in that area. That is not to say that you will be able to go to your doctor tomorrow… but it means that some of the most fundamental problems of regenerative medicine have been addressed in the mere ten years since that word was coined. Making individual stem cells that allow your own cells to be used for your own regeneration, breakthroughs that tell us it is very likely going to be possible to make any type of cell in any stage that we want. The first ones will be cells for one of the major diseases — it turns out that 8% of Americans suffer from diabetes. In some cities, 20% of the entire population suffers from diabetes. That is surely going to be one of the first targets, but it will not be the only target.</p><p>What do we do until we get to the time when we can replace with young, healthy cells those of our cells that are injured or damaged? That is where the other aspect of regenerative medicine comes in. The initial concept was that regenerative medicine could replace any part of our body that is injured by trauma, damaged by disease, or warn by time.</p><p>In the end, what we care about is function, not how that function is achieved. If it is achieved by some painless injection of a cell that finds its way in the body and starts producing young and healthy tissues, we will be very happy. If it is achieved by replacing a major joint with a piece of plastic or metal, so that we can walk when we could not… if it is replaced by a bit of electronics that allow us to see when we could not… if it is replaced by electrodes that sense our intension and cause our limbs to move when they could not… we will be much happier than we were before.</p><p>It is again in this field that the tremendous advances of modern science have come to bear. It is in the field of nanoprosthetics. It is in the field of being able to use a variety of different materials to replace our own materials. The one demonstration of where this is headed that you may have seen — we saw early prototypes in some of our early regenerative medicine meetings, but they are now much more advanced — is the implantation of sensing electrodes in the brains of monkeys that allow them to manipulate robotic arms with great facility. (Monkeys can be trained to play videogames, and would beat every single person in this room, by the way. The hand-eye coordination of a monkey who plays a videogame is really something to see. Eventually, your kids may be playing monkeys.)</p><p>In fact, what they have done is trained these monkeys with these implants to manipulate these robotic arms. They then restrain the monkeys’ own arms, and he learns to play the game and get his reward with the electronic arm. Eventually the brain adapts and the monkey can learn to use all three arms for whatever he wishes to do–play electronic games, feed himself, or reach across a continent to create an effect which he wants, through electronics. There are people here in Los Angeles trying to connect those electronic signals directly to muscle stimulation for paraplegics. Those are the kinds of advances that are being made, and must be made until we have the ability to regenerate the spinal column.</p><p>There is one other field that was referred to also in Aubrey’s excellent introduction. That was reaching into your metabolism and changing its speed. Now, why do we think that will work? You may have read about a whole series of studies in many different species, including mammals now, that caloric restriction extends life. In some cases it can double or even triple a lifespan. Modern genetics, the ability to understand the internal workings of cells, has allowed us to begin to pinpoint those key switches and begin to play with them with various drugs. The one that many of you may have heard of is the substance that is found in red wines, and now has synthetic analogs that are far more potent. We can reach in and begin to slow down the genetic clock, hopefully without the pain of severe dietary restriction.</p><p>All of this has happened in the last ten years. I am personally an optimist. In my career as a scientist working in the career of medicine, I have seen what appear to be miracles. In my days as a cancer researcher, I saw the survival of head and neck cancers change from 15% to 85%. It took us twenty years to do it, but it is a fact today. In my career as an AIDS researcher, I saw the disease go from one that was virtually fatal regardless of intervention to one that is manageable as a chronic disease today, if properly treated — another virtual miracle. I have seen that with systematic efforts, we have gone from the knowledge of a few hundred genes to all the genes of our species and the genes now of some one thousand additional species. We can do great things when we put our minds to it.</p><p>Progress over the past ten years in regenerative medicine and longevity has been truly remarkable. The next ten years, which most of us in this room will experience, is going to be more remarkable still.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*TjpVPf0fsI0rotNn.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8658ea84ffa5" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The International Embryome Initiative]]></title>
            <link>https://medium.com/@emergingtechnology/the-international-embryome-initiative-71e347830baa?source=rss-dc4be46c8af------2</link>
            <guid isPermaLink="false">https://medium.com/p/71e347830baa</guid>
            <category><![CDATA[michael-west]]></category>
            <category><![CDATA[life-extension]]></category>
            <dc:creator><![CDATA[/r/21dotco]]></dc:creator>
            <pubDate>Fri, 01 Jan 2016 07:40:25 GMT</pubDate>
            <atom:updated>2016-01-01T07:40:25.652Z</atom:updated>
            <cc:license>http://creativecommons.org/publicdomain/zero/1.0/</cc:license>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*TxuB_6oWvq0MaWbU.png" /></figure><p>July 21st, 2008</p><p>A pioneer in the field of stem cell research, Michael West, Ph.D., has served on the <a href="http://www.biotimeinc.com/">BioTime</a> Board of Directors since 2002 and has extensive academic and business experience in age-related degenerative diseases, telomerase molecular biology and human embryonic stem cell research and development.</p><p>At the free symposium organized by the Methuselah Foundation life-extension organization, he unveiled an online open sourced database, called the <a href="http://embryome.com/database/index.php">Embryome</a>, whose purpose is to help identify the hundreds of cell types that can be made from embryonic stem cells.</p><p>The following transcript of Michael West’s presentation at the Methuselah Foundation symposium entitled “Aging: The Disease, The Cure, The Implications” has not been approved by the speaker.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FOMZFypU4WRc%3Ffeature%3Doembed&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DOMZFypU4WRc&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FOMZFypU4WRc%2Fhqdefault.jpg&amp;key=d04bfffea46d4aeda930ec88cc64b87c&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/f14ae520e1000c899e316176f7f0322f/href">https://medium.com/media/f14ae520e1000c899e316176f7f0322f/href</a></iframe><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/0*s4hJUnwWqiYttNEr.png" /></figure><p><strong>The International Embryome Initiative</strong></p><p>I want to circle back to the first talk Dr. Haseltine gave. I don’t know about you guys, but I noticed there was rapt attention during what he said. Certainly, it has attracted me. I am a gerontologist, and my interest in my career has been not only to understand the biology of aging, but how can we learn something to improve the human condition and maybe even extend human longevity?</p><p>I am going to talk today about the cells Dr. Haseltine was talking about — these immortal cells. He talked about life and death in the human life cycle. I remember growing up watching <a href="http://en.wikipedia.org/wiki/Ben_Casey">Ben Casey</a> — I don’t know if any of you are old enough to remember that show? A couple hands. Remember the beginning? “Man, woman, birth, death, infinity.” I used to look at that, saying, that sounds profound.</p><p>Ever since then I have been entranced by the immortality of the species and how it’s accomplished. A simple way of putting it: we are made of cells, trillions of them, that have been proliferating backward in time all the way through hundreds of millions of years to the beginning of life on the planet, leaving no dead ancestors in their wake ever — or we would not be here. It is our somatic cells that are destined to die. All the cells in our body have this immortal legacy going backward in time millions of years and will face death for the first time ever in our lifetime.</p><p>What can we learn about the immortality of the species to transport those observations and discoveries of modern technologies into something that will really do something about human aging? That is what I am going to talk about today.</p><p>Aubrey mentioned I am an optimist. Maybe I am, because I am showing you a rising sun here. Actually, these are cells derived from these immortal cells, embryonic stem cells. Dr. Mark Perry here in the LA area took pictures of these some years ago.</p><p>There is a backdrop though, to talk about the properties. You probably all heard in the debate about embryonic stem cells, because they are from the root of human life, they can make everything in the human body. That is a first, ever. Medicine has never had a platform, a mechanism, to make and replace all of the cells in the human body.</p><p>As odd as it sounds, we can replace your carburetor or the tires of your car, but the leading cause of death in the United States is the loss of heart cells in your heart. That does not make a lot of sense, does it? We keep an antique car around forever, but we cannot keep the human body around.</p><p>These are a first platform. They make every kind of cell. Because of their being an immortal cell, they open the door to merging them with DNA technology. It is a merger of two technologies: modern genomics and cell biology, married together with these cells. You see it where these cells have been used to make mice — then we can go in an do all kinds of sophisticated changes to the DNA. There are human therapeutic applications, which California is funding, and of course a lot of research can be done with these cells as well. One of the most significant things as a gerontologist is that we believe that for the first time we can really capture these immortal cells that are transported from generation to generation — keeping them from going on an immortal cycle, but they are showing this immortality.</p><p>How do we know these are the immortal cells? All the cells, grown in the laboratory dish from the human body, age. This has been used for years to study the biology of aging. We predicted, based on all this biology, that these cells would be the only exception of a normal human cell that would proliferate forever, like the Energizer bunny. Sure enough, it did. These are the first human cells that were cultured that have this property of replicating without limit.</p><p>Now I want to switch from all this optimistic stuff to the realities. As Dr. Haseltine said, you can imagine now some pretty dramatic inventions. If these are really the cells that keep making us, and we can take a cell from you or me and transport it back in time to make these cells, then there will be lots of opportunities — that is the optimistic side. Let’s delve into the challenges, and that is where I want to spend the rest of tonight talking about. I’m talking about it, because I’m excited. I think we know how to deal with the challenges, and I want to walk you through that quickly, because I find that very encouraging.</p><p>To balance the rosy sun, I’m showing the stark, cold reality of the moon to lay out the challenges. Number one — and this is really a problem — because these cells are so powerful, they turn into everything in the human body. That is thousands of different kinds of cells — that’s a problem. Few of us who study anatomy, the cells and cell biology, can remember all the cells in the human body.</p><p>A second thing, there are no precise markers. Different kinds of cells decorate themselves with proteins on their surface that tell you if that is a liver cell, a heart cell, and so on. We don’t even know what those are in the early developing human. Because President Bush and previous administrations have banned federal funding for early embryo research, we really don’t know very much about these cells. If we had these wonderful cells that could cure diabetes, we don’t even know what properties they would have.</p><p>There is enormous complexity and a very poor understanding of these markers. You may have noticed that when some of the early companies that approached the FDA saying they want to start human clinical trials with these cells, the FDA replied, “They aren’t pure enough.” These are some of the challenges.</p><p>The way we looked at this, here is a very complex tree. These cells would be at the base of this tree, branching out into all the cells that make you and me. Imagine the tree suddenly getting out at least a hundred times more complex. That is closer to the reality of you and me. “How do we make a beta cell?” “How do we make a heart cell?”</p><p>There are two different ways you can do it. One would be, I want that “apple” up there, I can make a stick and a catcher’s mitt and “get it,” so to speak. Early technologies were going to figure out how to make a beta cell, but some of us were thinking about this and said, “Look, a lot of this we want to do in our lifetime. Let’s put a tarp under the tree and shake it, and take everything that falls out.”</p><p>That was the way the sequencing of the genome was suddenly accelerated. That was the way this field was accelerated.</p><p>All of this complexity that leads to all the different zebra stripes — we actually have invisible stripes on our body — all this complexity is in the human body. We invented a technology to to shake the tree, to shotgun clone all these cells that make up you and me — embryonic stem cells, in a purified form — without knowing how a heart cell forms.</p><p>This is the tarp we put under the tree. It is a combinatorial matrix approach where we tried a bunch of random, different ways of growing the cells, then we looked for cells that could grow up from a single cell. We call it “shotgun cloning.” Only in the last five to ten years could all of this be done with the immense increase in computing power and a lot of other techniques that scientists have available. We were going to take all of these cells, and then get the expression (the genes that are turned on and off) for all the cells, and then let computers run 24 hours a day for weeks, and reassemble the tree.</p><p>It is hard to see, but up at the top there is a branching tree, and those red spots are generated by computer, showing the genes that are very highly expressed. You can see the enormous diversity of cell types we have made this way. Basically shaking the tree, suddenly falling out of this are over 140 early lineages that make up you and me. What we suddenly realized was the complexity problem. We thought this was where we would be thirty years from now. Now, we suddenly have all these early precursors of muscle, teeth and the inner ear. The computer is giving us all these charts of markers, these things we so desperately needed to tell one cell type from another.</p><p>We went under a stream to collect a glass of water and suddenly, Niagara Falls. There was this enormous flood of information and cell types — cell types like this, by the way. This in the upper left is a propagating, purified culture of precursors to the brain. It can incorporate and regenerate the telencephalon in the brain — really amazing stuff.</p><p>In the top panel you can see some of these cells lit up. They are 100% pure because they were clonally isolated. We had suddenly solved this problem of separating these cells out. The fun part is that all the cells in our body have a zip code built into them that tells the cells where they are. You can identify homeobox genes (when you look at them in a developing mouse, as you can see in the lower left there) in the developing jaw or wherever. These cell lines on the right, you can see the histograms, give us these very clear zip codes. We can even tell where they would have been in the developing human.</p><p>All of this data, all of these cell lines, all the history that research scientists have done into the development of the mouse, is an enormous opportunity, but way too complicated. The DNA was a very complicated problem, billions of letters — how do we deal with this? It led to a field called “genomics,” which is the study of all the regulatory, coding sequences of the DNA and how we make sense of all this.</p><p>There is a new field emerging now called “embryomics,” which is the study of all of these cell lineages that make up the developing human, their markers and their properties. It’s just that, like genomics, it is <em>so</em> complicated. How do we do this?</p><p>What we have launched is an international embryome initiative. We have opened up on the internet a database at <a href="http://embryome.com/">embryome.com</a>, open sourced so that the whole world can join in and help us build out this tree and all its complexity. It’s sort of like Wikipedia. Here you are looking at the frontpage. Click on this simplified tree and it takes you to a far more detailed analysis of gene expression and a very precise nomenclature of every cell, its markers and its properties.</p><p>This has all happened in the last year. A lot of the critics have said embryonic stem cells still have not cured a disease. What I want to tell you is that we had to invent all new technologies. We are excited about how this is building out.</p><p>These are these immortal germline cells. They keep making new people. We know that by studying the clock of aging, the telomere. The clock of aging is wound at the very beginning of life. You can see these growth curves — they have these long lifespans compared with normal cells.</p><p>How could these cells be used in the next ten years? There are numerous examples I could give you, but one hopeful one — macular degeneration. This is the leading cause of blindness, due to the aging of our retina. These cells have now been made in a form that is appropriate to begin human clinical trials. You can see pictures of the cells on the lower right. When they become lost or dysfunctional in the back of the retina, they cause this cascade of pathology that is a leading cause of blindness in the elderly. The eye is a good place to start, I think. It is at least one of the top targets for how we hope these cells will eventually be used in medicine.</p><p>To summarize, I would argue that President Bush’s restrictions on these kinds of cells really angered a lot of people, because this was medicine and it should not be politics. It caused the voters of California to vote to fund the work themselves. Similarly, I think the whole scientific community is being engaged by this new technology. This new initiative will allow all those researchers to get together to try to delve into the complexity and the commensurate opportunity that these cells give us.</p><p>These are actually the ultimate young cell — an immortal cell — and able to make cells of any kind. The implications I think are obvious in medicine. These early embryonic cells have impressive plasticity, meaning they are used to building the human body, so they are very good at regenerating the human body. With the new technologies that we have now, finally we can have a very pure product that will be safe to use in humans. Ultimately, with these new technologies we now have the capability to take control of the human life cycle.</p><p>Woody Allen once said, on the immortality of the germline, some people would like to have immortality through their children, I would prefer to have immortality by not dying. That is really what we think we have here. We have captured the central mechanisms of immortality in the human species, and we can now manipulate it. At minimum, we hope we will be able to make some inroads in how we age.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=71e347830baa" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>